<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Acta Neuropathologica via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Acta Neuropathologica' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Acta+Neuropathologica&t=Acta+Neuropathologica&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 20:42:54 +0100</lastBuildDate>
        <item>
            <title>GNAQ and GNA11 mutations in melanocytomas of the central nervous system</title>
            <link>http://www.medworm.com/index.php?rid=5668691&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdt6219x63n040538%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-3DOI 10.1007/s00401-012-0948-xAuthors
		Rajmohan Murali, Department of Pathology, and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USAThomas Wiesner, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USAMarc K. Rosenblum, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USABoris C. Bastian, Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5668691</comments>
            <pubDate>Fri, 03 Feb 2012 17:51:26 +0100</pubDate>
            <guid isPermaLink="false">5668691</guid>        </item>
        <item>
            <title>An essential role for p38 MAPK in cerebellar granule neuron precursor proliferation</title>
            <link>http://www.medworm.com/index.php?rid=5660873&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk27r626737p4723q%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Development of the cerebellum occurs postnatally and is marked by a rapid proliferation of cerebellar granule neuron precursors
 (CGNPs). CGNPs are the cells of origin for SHH-driven medulloblastoma, the most common malignant brain tumor in children.
 Here, we investigated the role of ERK, JNK, and p38 mitogen-activated protein kinases in CGNP proliferation. We found high
 levels of p38α in proliferating CGNPs. Concomitantly, members of the p38 pathway, such as ASK1, MKK3 and ATF-2, were also
 elevated. Inhibition of the Shh pathway or CGNP proliferation blunts p38α levels, irrespective of Shh treatment. Strikingly,
 p38α levels were high in vivo in the external granule layer of the postnatal cerebellum, Shh-dependent mouse medulloblastomas
 and human medulloblastoma...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660873</comments>
            <pubDate>Thu, 02 Feb 2012 18:15:33 +0100</pubDate>
            <guid isPermaLink="false">5660873</guid>        </item>
        <item>
            <title>TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation</title>
            <link>http://www.medworm.com/index.php?rid=5660874&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft46042r916016564%2F</link>
            <description>We present the first neuropathological description of a patient with
 a NIPA1 mutation, and clinical phenotype of complicated HSP with motor neuron disease-like syndrome and cognitive decline. Postmortem
 examination revealed degeneration of lateral corticospinal tracts and dorsal columns with motor neuron loss. TDP-43 immunostaining
 showed widespread spinal cord and cerebral skein-like and round neuronal cytoplasmic inclusions. We ruled out NIPA1 mutations in 419 additional cases of motor neuron disease. These findings suggest that hereditary spastic paraplegia due
 to NIPA1 mutations could represent a TDP-43 proteinopathy.
 
 
	Content Type Journal ArticleCategory Case ReportsPages 1-7DOI 10.1007/s00401-012-0947-yAuthors
		Maria Martinez-Lage, Department of Pathology and Laboratory Medi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660874</comments>
            <pubDate>Thu, 02 Feb 2012 18:15:30 +0100</pubDate>
            <guid isPermaLink="false">5660874</guid>        </item>
        <item>
            <title>Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI</title>
            <link>http://www.medworm.com/index.php?rid=5660875&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7181503147wq151%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-4DOI 10.1007/s00401-012-0945-0Authors
		Veronica A. Kinsler, Department of Paediatric Dermatology, Great Ormond Street Hospital for Children NHS Trust, London, UKSimon M. L. Paine, Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, UKGlenn W. Anderson, Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, UKD. Saraji Wijesekara, Department of Neurology, Great Ormond Street Hospital for Children NHS Trust, London, UKNeil J. Sebire, Department of Histopathology, Great Ormond Street Hospital for Children NHS Trust, London, UKWui K. Chong, Department of Neuroradiology, Great Ormond Street Hospital for Children NHS Trust, London, UKWilliam Harkness, Departmen...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5660875</comments>
            <pubDate>Tue, 31 Jan 2012 16:48:19 +0100</pubDate>
            <guid isPermaLink="false">5660875</guid>        </item>
        <item>
            <title>Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study</title>
            <link>http://www.medworm.com/index.php?rid=5639493&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr737h5km36145645%2F</link>
            <description>In this study, we examined Aβ pathology
 in an individual who had clinical diagnoses of probable dementia with Lewy bodies and possible Alzheimer’s disease (AD) but
 with no detectable [C-11]PiB PET retention ([C-11]PiB(−)) when imaged 17&amp;nbsp;months prior to death. Brain samples were processed
 in parallel with region-matched samples from an individual with a clinical diagnosis of probable AD and a positive [C-11]PiB
 PET scan ([C-11]PiB(+)) when imaged 10&amp;nbsp;months prior to death. In the [C-11]PiB(−) case, Aβ plaques were sparse, occupying
 less than 2% cortical area, and were weakly labeled with 6-CN-PiB, a highly fluorescent derivative of PiB. In contrast, Aβ
 plaques occupied up to 12% cortical area in the [C-11]PiB(+) case, and were intensely labeled with 6-CN-PIB. The [C-...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639493</comments>
            <pubDate>Tue, 24 Jan 2012 06:52:02 +0100</pubDate>
            <guid isPermaLink="false">5639493</guid>        </item>
        <item>
            <title>Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler’s murine encephalomyelitis</title>
            <link>http://www.medworm.com/index.php?rid=5639494&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh174650623t51212%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Matrix metalloproteinases (MMPs) are a family of extracellular proteases involved in the pathogenesis of demyelinating diseases
 like multiple sclerosis (MS). The aim of the present study was to investigate whether MMPs induce direct myelin degradation,
 leukocyte infiltration, disruption of the blood–brain barrier (BBB), and/or extracellular matrix remodeling in the pathogenesis
 of Theiler’s murine encephalomyelitis (TME), a virus-induced model of MS. During the demyelinating phase of TME, the highest
 transcriptional upregulation was detected for Mmp12, followed by Mmp3. Mmp12
 −/− mice showed reduced demyelination, macrophage infiltration, and motor deficits compared with wild-type- and Mmp3 knock-out mice. However, BBB remained unaltered, and the amount of ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639494</comments>
            <pubDate>Tue, 24 Jan 2012 06:52:01 +0100</pubDate>
            <guid isPermaLink="false">5639494</guid>        </item>
        <item>
            <title>Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease</title>
            <link>http://www.medworm.com/index.php?rid=5639495&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F16n23w564q8x6u05%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A fundamental step in pathophysiology of prion diseases is the conversion of the host encoded prion protein (PrPC) into a misfolded isoform (PrPSc) that accumulates mainly in neuronal but also non-neuronal tissues. Prion diseases are transmissible within and between species.
 In a subset of prion diseases, peripheral prion uptake and subsequent transport to the central nervous system are key to disease
 initiation. The involvement of retroviruses in this process has been postulated based on the findings that retroviral infections
 enhance the spread of prion infectivity and PrPSc from cell to cell in vitro. To study whether retroviral infection influences the phenotype of prion disease or the spread
 of prion infectivity and PrPSc in vivo, we developed a murine model wi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639495</comments>
            <pubDate>Tue, 24 Jan 2012 06:51:59 +0100</pubDate>
            <guid isPermaLink="false">5639495</guid>        </item>
        <item>
            <title>Saccular intracranial aneurysm: pathology and mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5611111&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx56617x632142n47%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Saccular intracranial aneurysms (sIA) are pouch-like pathological dilatations of intracranial arteries that develop when the
 cerebral artery wall becomes too weak to resist hemodynamic pressure and distends. Some sIAs remain stable over time, but
 in others mural cells die, the matrix degenerates, and eventually the wall ruptures, causing life-threatening hemorrhage.
 The wall of unruptured sIAs is characterized by myointimal hyperplasia and organizing thrombus, whereas that of ruptured sIAs
 is characterized by a decellularized, degenerated matrix and a poorly organized luminal thrombus. Cell-mediated and humoral
 inflammatory reaction is seen in both, but inflammation is clearly associated with degenerated and ruptured walls. Inflammation,
 however, seems to be a rea...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611111</comments>
            <pubDate>Tue, 17 Jan 2012 07:11:20 +0100</pubDate>
            <guid isPermaLink="false">5611111</guid>        </item>
        <item>
            <title>Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial</title>
            <link>http://www.medworm.com/index.php?rid=5611114&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F60r78622652k1j14%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glioblastoma (GBM) is a morphologically heterogeneous tumor type with a median survival of only 15&amp;nbsp;months in clinical trial
 populations. However, survival varies greatly among patients. As part of a central pathology review, we addressed the question
 if patients with GBM displaying distinct morphologic features respond differently to combined chemo-radiotherapy with temozolomide.
 Morphologic features were systematically recorded for 360 cases with particular focus on the presence of an oligodendroglioma-like
 component and respective correlations with outcome and relevant molecular markers. GBM with an oligodendroglioma-like component
 (GBM-O) represented 15% of all confirmed GBM (52/339) and was not associated with a more favorable outcome. GBM-O encompassed
 a...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611114</comments>
            <pubDate>Tue, 17 Jan 2012 07:11:19 +0100</pubDate>
            <guid isPermaLink="false">5611114</guid>        </item>
        <item>
            <title>The “go or grow” potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress</title>
            <link>http://www.medworm.com/index.php?rid=5611113&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe7mg64x0201478l0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glioblastoma (GBM), the most common malignant brain tumor, is among the most lethal neoplasms, with a median survival of approximately
 1&amp;nbsp;year. Prognosis is poor since GBMs possess a strong migratory and highly invasive potential, making complete surgical resection
 impossible. Reduced expression of carboxypeptidase E (CPE), a neuropeptide-processing enzyme, in a cell death-resistant glioma
 cell line and lower CPE expression levels in the cohort of GBM samples of The Cancer Genome Atlas compared to normal brain
 control specimens prompted us to analyze the function of CPE as a putative tumor suppressor gene. In our samples, CPE was
 also reduced in GBM compared to normal brain with the strongest loss in cells surrounding hypoxic tumor areas as well as in
 most gli...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611113</comments>
            <pubDate>Tue, 17 Jan 2012 07:11:19 +0100</pubDate>
            <guid isPermaLink="false">5611113</guid>        </item>
        <item>
            <title>Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5611112&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn844026jh7671078%2F</link>
            <description>In conclusion, our results delineate the mechanisms underlying the deregulation and reveal the functional significance
 of HMGA1 in controlling MB cell growth and migration/invasion. Importantly, the results highlight the therapeutic potential
 of targeting HMGA1 in MB patients.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-19DOI 10.1007/s00401-011-0934-8Authors
		Kin-Mang Lau, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Room 38018, 1/F, Clinical Sciences Building, Shatin, New Territories, Hong KongQueeny Kwan Yi Chan, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Room 38018, 1/F, Clinical Sciences Building, Shatin, New Territories, Hong Ko...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5611112</comments>
            <pubDate>Tue, 17 Jan 2012 07:11:19 +0100</pubDate>
            <guid isPermaLink="false">5611112</guid>        </item>
        <item>
            <title>Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p</title>
            <link>http://www.medworm.com/index.php?rid=5573031&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8117564u77k31500%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Two studies recently identified a GGGGCC hexanucleotide repeat expansion in a non-coding region of the chromosome 9 open-reading
 frame 72 gene (C9ORF72) as the cause of chromosome 9p-linked amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In a cohort
 of 231 probands with ALS, we identified the C9ORF72 mutation in 17 familial (27.4%) and six sporadic (3.6%) cases. Patients with the mutation presented with typical motor features
 of ALS, although subjects with the C9ORF72 mutation had more frequent bulbar onset, compared to those without this mutation. Dementia was significantly more common
 in ALS patients and families with the C9ORF72 mutation and was usually early-onset FTD. There was striking clinical heterogeneity among the members of individu...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573031</comments>
            <pubDate>Fri, 06 Jan 2012 16:44:36 +0100</pubDate>
            <guid isPermaLink="false">5573031</guid>        </item>
        <item>
            <title>Asymmetry of neurodegenerative disease-related pathologies: a cautionary note</title>
            <link>http://www.medworm.com/index.php?rid=5573032&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy132u08661672288%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-4DOI 10.1007/s00401-011-0936-6Authors
		Harald Stefanits, Institute of Neurology, Medical University of Vienna, AKH 4J, Währinger Gürtel 18-20, 1097 Vienna, AustriaHerbert Budka, Institute of Neurology, Medical University of Vienna, AKH 4J, Währinger Gürtel 18-20, 1097 Vienna, AustriaGabor G. Kovacs, Institute of Neurology, Medical University of Vienna, AKH 4J, Währinger Gürtel 18-20, 1097 Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5573032</comments>
            <pubDate>Thu, 05 Jan 2012 17:08:08 +0100</pubDate>
            <guid isPermaLink="false">5573032</guid>        </item>
        <item>
            <title>Brain metastases: pathobiology and emerging targeted therapies</title>
            <link>http://www.medworm.com/index.php?rid=5561986&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F75201h1q22k3u37p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain metastases (BM) are common in cancer patients and are associated with high morbidity and poor prognosis, even after
 intensive multimodal therapy including resection, radiotherapy (stereotactic radiosurgery or whole brain radiotherapy) and
 chemotherapy. However, advances in the understanding of the pathobiology of BM and the development of molecular targeted agents
 hold promise for improved prophylaxis and therapy of BM. Here we provide a comprehensive review of the current concepts on
 mechanisms of the brain-metastatic cascade involving hematogenous dissemination of tumor cells, attachment to microvessel
 endothelial cells, extravasation into the brain, interaction with the local microenvironment, angiogenesis and intraparenchymal
 proliferation. Transendothel...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561986</comments>
            <pubDate>Mon, 02 Jan 2012 16:53:26 +0100</pubDate>
            <guid isPermaLink="false">5561986</guid>        </item>
        <item>
            <title>Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5561987&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx0p53621q436k7x3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;While cognitive deficits are increasingly recognized as common symptoms in amyotrophic lateral sclerosis (ALS), the underlying
 histopathologic basis for this is not known, nor has the relevance of neuroinflammatory mechanisms and microglial activation
 to cognitive impairment (CI) in ALS been systematically analyzed. Staining for neurodegenerative disease pathology, TDP-43,
 and microglial activation markers (CD68, Iba1) was performed in 102 autopsy cases of ALS, and neuropathology data were related
 to clinical and neuropsychological measures. ALS with dementia (ALS-D) and ALS with impaired executive function (ALS-Ex) patients
 showed significant microglial activation in middle frontal and superior or middle temporal (SMT) gyrus regions, as well as
 significant neuron...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561987</comments>
            <pubDate>Sat, 31 Dec 2011 06:37:13 +0100</pubDate>
            <guid isPermaLink="false">5561987</guid>        </item>
        <item>
            <title>Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes</title>
            <link>http://www.medworm.com/index.php?rid=5561988&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu77770v6m2347k66%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neoplasms of the peripheral nerve sheath represent essential clinical manifestations of the syndromes known as the neurofibromatoses.
 Although involvement of multiple organ systems, including skin, central nervous system, and skeleton, may also be conspicuous,
 peripheral nerve neoplasia is often the most important and frequent cause of morbidity in these patients. Clinical characteristics
 of neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) have been extensively described and studied during the
 last century, and the identification of mutations in the NF1 and NF2 genes by contemporary molecular techniques have created a separate multidisciplinary field in genetic medicine. In schwannomatosis,
 the most recent addition to the neurofibromatosis group, p...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5561988</comments>
            <pubDate>Fri, 30 Dec 2011 16:42:01 +0100</pubDate>
            <guid isPermaLink="false">5561988</guid>        </item>
        <item>
            <title>News from the powerhouses</title>
            <link>http://www.medworm.com/index.php?rid=5526949&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw5222781x653121w%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-2DOI 10.1007/s00401-011-0931-yAuthors
		Stephan Frank, Division of Neuropathology, Institute of Pathology, Schönbeinstrasse 40, 4031 Basel, SwitzerlandMarkus Tolnay, Division of Neuropathology, Institute of Pathology, Schönbeinstrasse 40, 4031 Basel, Switzerland
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5526949</comments>
            <pubDate>Sat, 17 Dec 2011 16:42:05 +0100</pubDate>
            <guid isPermaLink="false">5526949</guid>        </item>
        <item>
            <title>Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration</title>
            <link>http://www.medworm.com/index.php?rid=5516338&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62w34tt713613731%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research efforts during the last decade have deciphered the basic molecular mechanisms governing mitochondrial fusion and
 fission. We now know that in mammalian cells mitochondrial fission is mediated by the large GTPase dynamin-related protein
 1 (Drp1) acting in concert with outer mitochondrial membrane (OMM) proteins such as Fis1, Mff, and Mief1. It is also generally
 accepted that organelle fusion depends on the action of three large GTPases: mitofusins (Mfn1, Mfn2) mediating membrane fusion
 on the OMM level, and Opa1 which is essential for inner mitochondrial membrane fusion. Significantly, mutations in Drp1, Mfn2,
 and Opa1 have causally been linked to neurodegenerative conditions. Despite this knowledge, crucial questions such as to how
 fission of the inner an...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516338</comments>
            <pubDate>Fri, 16 Dec 2011 16:57:06 +0100</pubDate>
            <guid isPermaLink="false">5516338</guid>        </item>
        <item>
            <title>Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts</title>
            <link>http://www.medworm.com/index.php?rid=5516339&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa7w4756nt1773363%2F</link>
            <description>This study consists of two parts: (1) an observational study using postmortem human brains (n&amp;nbsp;=&amp;nbsp;31) to determine the association between CAA and CMIs, and (2) an experimental study to determine whether hypoperfusion
 worsens CAA and induces CMIs in a CAA mouse model. In postmortem human brains, the density of CMIs was 0.113/cm2 in mild, 0.584/cm2 in moderate, and 4.370/cm2 in severe CAA groups with a positive linear correlation (r&amp;nbsp;=&amp;nbsp;0.6736, p&amp;nbsp;&amp;lt;&amp;nbsp;0.0001). Multivariate analysis revealed that, among seven variables (age, disease, senile plaques, neurofibrillary tangles,
 CAA, atherosclerosis and white matter damage), only the severity of CAA was a significant multivariate predictor of CMIs (p&amp;nbsp;=&amp;nbsp;0.0022). Consistent with the data from human brains, CAA ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516339</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:46 +0100</pubDate>
            <guid isPermaLink="false">5516339</guid>        </item>
        <item>
            <title>Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons</title>
            <link>http://www.medworm.com/index.php?rid=5516340&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb8477m853m3t5180%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fibrillar αSynuclein is the major constituent of Lewy bodies and Lewy neurites, the protein deposits characteristic for Parkinson’s
 disease (PD). Multiplications of the αSynuclein gene, as well as point mutations cause familial PD. However, the exact role
 of αSynuclein in neurodegeneration remains uncertain. Recent research in invertebrates has suggested that oligomeric rather
 than fibrillizing αSynuclein mediates neurotoxicity. To investigate the impact of αSynuclein aggregation on the progression
 of neurodegeneration, we expressed variants with different fibrillation propensities in the rat substantia nigra (SN) by means
 of recombinant adeno-associated viral (AAV) vectors. The formation of proteinase K-resistant αSynuclein aggregates was correlated
 to th...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5516340</comments>
            <pubDate>Tue, 13 Dec 2011 17:05:28 +0100</pubDate>
            <guid isPermaLink="false">5516340</guid>        </item>
        <item>
            <title>Entorhinal verrucae geometry is coincident and correlates with Alzheimer’s lesions: a combined neuropathology and high-resolution ex vivo MRI analysis</title>
            <link>http://www.medworm.com/index.php?rid=5506732&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F60705x5671203412%2F</link>
            <description>This study characterizes novel methods
 to measure individual entorhinal verruca size, and shows that verrucae size correlates to Alzheimer’s pathology. Taken together,
 these results suggest that verrucae may have the potential to serve as an early and specific morphological marker for mild
 cognitive impairment and Alzheimer’s disease.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-12DOI 10.1007/s00401-011-0929-5Authors
		Jean C. Augustinack, Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Building 149–13th St., Room 2301, Charlestown, MA 02129, USAKristen E. Huber, Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Building 149–13th St., Room ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5506732</comments>
            <pubDate>Mon, 12 Dec 2011 17:17:04 +0100</pubDate>
            <guid isPermaLink="false">5506732</guid>        </item>
        <item>
            <title>Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms</title>
            <link>http://www.medworm.com/index.php?rid=5495928&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb7062782837w5361%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurofibromas, schwannomas and malignant peripheral nerve sheath tumors (MPNSTs) all arise from the Schwann cell lineage.
 Despite their common origin, these tumor types have distinct pathologies and clinical behaviors; a growing body of evidence
 indicates that they also arise via distinct pathogenic mechanisms. Identification of the genes that are mutated in genetic
 diseases characterized by the development of either neurofibromas and MPNSTs [neurofibromatosis type 1 (NF1)] or schwannomas
 [neurofibromatosis type 2 (NF2), schwannomatosis and Carney complex type 1] has greatly advanced our understanding of these
 mechanisms. The development of genetically engineered mice with ablation of NF1, NF2, SMARCB1/INI1 or PRKAR1A has confirmed the key role these genes play in ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495928</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:02 +0100</pubDate>
            <guid isPermaLink="false">5495928</guid>        </item>
        <item>
            <title>Hyperphosphorylated tau in young and middle-aged subjects</title>
            <link>http://www.medworm.com/index.php?rid=5495930&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F28414wh768534166%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The brain tissue obtained from ninety-five cognitively unimpaired subjects, with ages ranging from 22 to 50&amp;nbsp;years upon death,
 were immunohistochemically assessed for neurodegenerative changes, i.e., hyperphosphorylated tau (HPτ) and β-amyloid (Aβ)
 pathology in predilection neuroanatomical areas. HPτ pathology was observed in the transentorhinal cortex and/or the locus
 coeruleus (LC) in 33% of the subjects, without any obvious risk factors known to alter the microtubule-associated protein.
 HPτ pathology was noted in the LC in 25 out of 83 subjects (30%), lacking concomitant cortical Aβ or transentorhinal HPτ pathology.
 This observation was present even when assessing only one routine section of 7&amp;nbsp;μm thickness. The recent suggestion of prion-like
 p...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495930</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:01 +0100</pubDate>
            <guid isPermaLink="false">5495930</guid>        </item>
        <item>
            <title>Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5495929&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fap1223k043p17k1t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Camptocormia is a highly disabling syndrome that occurs in various diseases but is particularly associated with Parkinson’s
 disease (PD). Although first described nearly 200&amp;nbsp;years ago, the morphological changes associated with camptocormia are still
 under debate and the pathophysiology is unknown. We analyzed paraspinal muscle biopsies of 14 PD patients with camptocormia
 and compared the findings to sex-matched postmortem controls of comparable age to exclude biopsy site-specific changes. Camptocormia
 in PD showed a consistent lesion pattern composed of myopathic changes with type-1 fiber hypertrophy, loss of type-2 fibers,
 loss of oxidative enzyme activity, and acid phosphatase reactivity of lesions. Ultrastructurally, myofibrillar disorganization
 and Z-ba...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495929</comments>
            <pubDate>Sat, 10 Dec 2011 16:55:01 +0100</pubDate>
            <guid isPermaLink="false">5495929</guid>        </item>
        <item>
            <title>Biological and clinical heterogeneity of MYCN-amplified medulloblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5495931&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuu636721744488w8%2F</link>
            <description>In conclusion, we demonstrate considerable heterogeneity within MYCN-MB in terms of genetics, tumor biology, and clinical outcome. Thus, assessment of disease group and 10q copy-number status
 may improve risk stratification of this group and may delineate MYCN-MB with the same dismal prognosis as MYC amplified tumors. Furthermore, based on the enrichment of MYCN and GLI2 amplifications in SHH-driven medulloblastoma, amplification of these downstream signaling intermediates should be taken into
 account before a patient is enrolled into a clinical trial using a smoothened inhibitor.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-13DOI 10.1007/s00401-011-0918-8Authors
		Andrey Korshunov, Department of Neuropathology, University of Heidelberg, Heidelberg, GermanyMarc Remke, ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5495931</comments>
            <pubDate>Thu, 08 Dec 2011 18:24:19 +0100</pubDate>
            <guid isPermaLink="false">5495931</guid>        </item>
        <item>
            <title>Neurodegeneration as a consequence of failed mitochondrial maintenance</title>
            <link>http://www.medworm.com/index.php?rid=5488489&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy22m260577635101%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Maintaining the functional integrity of mitochondria is pivotal for cellular survival. It appears that neuronal homeostasis
 depends on high-fidelity mitochondria, in particular. Consequently, mitochondrial dysfunction is a fundamental problem associated
 with a significant number of neurological diseases, including Parkinson’s disease (PD), Huntington’s disease (HD), Alzheimer’s
 disease (AD), amyotrophic lateral sclerosis (ALS) and various peripheral neuropathies, as well as the normal aging process.
 To ensure optimal mitochondrial function, diverse, evolutionarily conserved mitochondrial quality control mechanisms are in
 place, including the scavenging of toxic reactive oxygen species (ROS) and degradation of damaged mitochondrial proteins,
 but also turnover...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5488489</comments>
            <pubDate>Tue, 06 Dec 2011 07:01:37 +0100</pubDate>
            <guid isPermaLink="false">5488489</guid>        </item>
        <item>
            <title>MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5477992&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl527n0148365p400%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The MYC oncogenes are the most commonly amplified loci in medulloblastoma, and have previously been proposed as biomarkers of adverse
 disease prognosis by us and others. Here, we report focussed and comprehensive investigations of MYCC, MYCN and MYCL in an extensive medulloblastoma cohort (n&amp;nbsp;=&amp;nbsp;292), aimed to define more precisely their biological significance and optimal clinical application to direct improved
 disease risk-stratification and individualisation of therapy. MYCC and MYCN expression elevations were multifactorial, associated with high-risk (gene amplification, large-cell/anaplastic pathology
 (LCA)) and favourable-risk (WNT/SHH molecular subgroups) disease features. Highly variable cellular gene amplification patterns
 underlay overall MYC copy ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477992</comments>
            <pubDate>Fri, 02 Dec 2011 17:30:50 +0100</pubDate>
            <guid isPermaLink="false">5477992</guid>        </item>
        <item>
            <title>MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5477993&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn5644r3713705j18%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The contribution of microRNAs to the initiation, progression, and metastasis of medulloblastoma (MB) remains poorly understood.
 Metastatic dissemination at diagnosis is present in about 30% of MB patients, and is associated with a dismal prognosis. Using
 microRNA expression profiling, we demonstrate that the retinal miR-183–96–182 cluster on chromosome 7q32 is highly overexpressed
 in non-sonic hedgehog MBs (non-SHH-MBs). Expression of miR-182 and miR-183 is associated with cerebellar midline localization,
 and miR-182 is significantly overexpressed in metastatic MB as compared to non-metastatic tumors. Overexpression of miR-182
 in non-SHH-MB increases and knockdown of miR-182 decreases cell migration in vitro. Xenografts overexpressing miR-182 invaded
 adjacent ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477993</comments>
            <pubDate>Thu, 01 Dec 2011 19:29:53 +0100</pubDate>
            <guid isPermaLink="false">5477993</guid>        </item>
        <item>
            <title>Molecular subgroups of medulloblastoma: the current consensus</title>
            <link>http://www.medworm.com/index.php?rid=5477994&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F636123n447361k6p%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Medulloblastoma, a small blue cell malignancy of the cerebellum, is a major cause of morbidity and mortality in pediatric
 oncology. Current mechanisms for clinical prognostication and stratification include clinical factors (age, presence of metastases,
 and extent of resection) as well as histological subgrouping (classic, desmoplastic, and large cell/anaplastic histology).
 Transcriptional profiling studies of medulloblastoma cohorts from several research groups around the globe have suggested
 the existence of multiple distinct molecular subgroups that differ in their demographics, transcriptomes, somatic genetic
 events, and clinical outcomes. Variations in the number, composition, and nature of the subgroups between studies brought
 about a consensus conference in...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5477994</comments>
            <pubDate>Thu, 01 Dec 2011 19:29:51 +0100</pubDate>
            <guid isPermaLink="false">5477994</guid>        </item>
        <item>
            <title>Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI</title>
            <link>http://www.medworm.com/index.php?rid=5459538&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjqjhm6m210515557%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Focal cortical dysplasias (FCD) which represent a composite group of cortical malformations are increasingly recognized as
 morphological substrate for severe therapy-refractory epilepsy in children and young adults. However, presurgical evaluation
 remains challenging as not all FCD variants can be reliably detected by high-resolution magnetic resonance imaging (MRI).
 Here, we studied a cohort of 52 epilepsy patients with neuropathological evidence for FCD using the 2011 classification of
 the International League against Epilepsy (ILAE) and systematically analysed those histopathologic features applicable also
 for MRI diagnostics. Histopathologic parameters included quantitative measurements of cellular profiles, cortical thickness,
 heterotopic neurons in white mat...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5459538</comments>
            <pubDate>Sat, 26 Nov 2011 16:48:46 +0100</pubDate>
            <guid isPermaLink="false">5459538</guid>        </item>
        <item>
            <title>In memoriam: Bernd Walter Scheithauer (1946–2011)</title>
            <link>http://www.medworm.com/index.php?rid=5450263&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg521130p29881gw8%2F</link>
            <description>Content Type Journal ArticleCategory ObituaryPages 1-2DOI 10.1007/s00401-011-0917-9Authors
		Caterina Giannini, Mayo Clinic, Rochester, MN, USA
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450263</comments>
            <pubDate>Thu, 24 Nov 2011 17:45:14 +0100</pubDate>
            <guid isPermaLink="false">5450263</guid>        </item>
        <item>
            <title>Vascular endothelial growth factor induces contralesional corticobulbar plasticity and functional neurological recovery in the ischemic brain</title>
            <link>http://www.medworm.com/index.php?rid=5450264&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl72k00747723h01g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vascular endothelial growth factor (VEGF) is a potent angiogenic factor, which also has neuroprotective activity. In view
 of these dual actions on vessels and neurons, we were interested whether VEGF promotes long distance axonal plasticity in
 the ischemic brain. Herein, we show that VEGF promotes neurological stroke recovery in mice when delivered in a delayed way
 starting 3&amp;nbsp;days after middle cerebral artery occlusion. Using anterograde tract-tracing experiments that we combined with
 histochemical and molecular biological studies, we demonstrate that although VEGF promoted angiogenesis predominantly in the
 ischemic hemisphere, pronounced axonal sprouting was induced by VEGF in the contralesional, but not the ipsilesional corticobulbar
 system. Corticobulbar p...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450264</comments>
            <pubDate>Wed, 23 Nov 2011 16:39:24 +0100</pubDate>
            <guid isPermaLink="false">5450264</guid>        </item>
        <item>
            <title>Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death</title>
            <link>http://www.medworm.com/index.php?rid=5450265&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu1264p5x3717l72g%2F</link>
            <description>In conclusion, we have generated a global view of the methylation profile
 of ependymoma. The data suggests epigenetic silencing of tumor suppressor genes is an important mechanism in the pathogenesis
 of supratentorial and spinal, but not posterior fossa ependymomas. Hypermethylation correlated with a decrease in expression
 of a number of tumor suppressor genes and pathways that could be playing an important role in tumor pathogenesis.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-15DOI 10.1007/s00401-011-0904-1Authors
		Hazel A. Rogers, Children’s Brain Tumour Research Centre, D Floor Medical School, Queen’s Medical Centre, University of Nottingham, Nottingham, NG7 2UH UKJohn-Paul Kilday, Children’s Brain Tumour Research Centre, D Floor Medical School, Queen’s ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5450265</comments>
            <pubDate>Wed, 23 Nov 2011 16:39:22 +0100</pubDate>
            <guid isPermaLink="false">5450265</guid>        </item>
        <item>
            <title>Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology</title>
            <link>http://www.medworm.com/index.php?rid=5442972&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F338530l0t85t5hn6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Research into amyotrophic lateral sclerosis (ALS) has been stimulated by a series of genetic and molecular pathology discoveries.
 The hallmark neuronal cytoplasmic inclusions of sporadic ALS (sALS) predominantly comprise a nuclear RNA processing protein,
 TDP-43 encoded by the gene TARDBP, a discovery that emerged from high throughput analysis of human brain tissue from patients with frontotemporal dementia
 (FTD) who share a common molecular pathology with ALS. The link between RNA processing and ALS was further strengthened by
 the discovery that another genetic locus linking familial ALS (fALS) and FTD was due to mutation of the fused in sarcoma (FUS) gene. Of potentially even greater importance it emerges that TDP-43 accumulation and inclusion formation characteris...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442972</comments>
            <pubDate>Mon, 21 Nov 2011 18:09:06 +0100</pubDate>
            <guid isPermaLink="false">5442972</guid>        </item>
        <item>
            <title>An autopsy case of adult-onset hereditary spastic paraplegia type 2 with a novel mutation in exon 7 of the proteolipid protein 1 gene</title>
            <link>http://www.medworm.com/index.php?rid=5442974&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj1138258558410r3%2F</link>
            <description>We report an autopsy case of rare adult-onset spastic paraplegia type 2 (SPG2) with a novel missense mutation in exon 7 of
 the proteolipid protein 1 gene (PLP1). The patient was a 67-year-old man whose elder brother had died of a similar disease with onset in his 40s. Thirty-three
 years before death at the age of 35, he noticed difficulty in walking. He gradually became abasic over a period of 6&amp;nbsp;years.
 He also developed progressive dementia and eventually became bed-ridden by 28&amp;nbsp;years after onset. At autopsy, gross inspection
 revealed diffuse, moderate atrophy of the cerebrum with a dilated ventricular system and softening of the white matter throughout
 the central nervous system (CNS). Histopathologically, the CNS showed widespread myelin pallor in the white matter. By cont...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442974</comments>
            <pubDate>Sat, 19 Nov 2011 16:51:38 +0100</pubDate>
            <guid isPermaLink="false">5442974</guid>        </item>
        <item>
            <title>National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach</title>
            <link>http://www.medworm.com/index.php?rid=5442973&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3370885p74700063%2F</link>
            <description>We present a practical guide for the implementation of recently revised National Institute on Aging–Alzheimer’s Association
 guidelines for the neuropathologic assessment of Alzheimer’s disease (AD). Major revisions from previous consensus criteria
 are: (1) recognition that AD neuropathologic changes may occur in the apparent absence of cognitive impairment, (2) an “ABC”
 score for AD neuropathologic change that incorporates histopathologic assessments of amyloid β deposits (A), staging of neurofibrillary
 tangles (B), and scoring of neuritic plaques (C), and (3) more detailed approaches for assessing commonly co-morbid conditions
 such as Lewy body disease, vascular brain injury, hippocampal sclerosis, and TAR DNA binding protein (TDP)-43 immunoreactive
 inclusions. Recommenda...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442973</comments>
            <pubDate>Sat, 19 Nov 2011 16:51:38 +0100</pubDate>
            <guid isPermaLink="false">5442973</guid>        </item>
        <item>
            <title>Optineurin is colocalized with ubiquitin in Marinesco bodies</title>
            <link>http://www.medworm.com/index.php?rid=5442975&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F286t61q75ln4x1u7%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-4DOI 10.1007/s00401-011-0915-yAuthors
		Claudia Schwab, Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, CanadaSheng Yu, Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, CanadaPatrick L. McGeer, Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442975</comments>
            <pubDate>Sat, 19 Nov 2011 16:51:37 +0100</pubDate>
            <guid isPermaLink="false">5442975</guid>        </item>
        <item>
            <title>The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain</title>
            <link>http://www.medworm.com/index.php?rid=5442976&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fhx77qm1701q5332k%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The deposition of the β-amyloid (Aβ) peptide in senile plaques and cerebral Aβ-amyloid angiopathy can be seeded in β-amyloid
 precursor protein (APP)-transgenic mice by the intracerebral infusion of brain extracts containing aggregated Aβ. Previous
 studies of seeded β-amyloid induction have used relatively short incubation periods to dissociate seeded β-amyloid induction
 from endogenous β-amyloid deposition of the host, thus precluding the analysis of the impact of age and extended incubation
 periods on the instigation and spread of Aβ lesions in brain. In the present study using R1.40 APP-transgenic mice (which
 do not develop endogenous Aβ deposition up to 15&amp;nbsp;months of age) we show that: (1) seeding at 9&amp;nbsp;months of age does not induce
 more Aβ d...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442976</comments>
            <pubDate>Sat, 19 Nov 2011 16:51:36 +0100</pubDate>
            <guid isPermaLink="false">5442976</guid>        </item>
        <item>
            <title>C9ORF72, the new gene on the block, causes C9FTD/ALS: new insights provided by neuropathology</title>
            <link>http://www.medworm.com/index.php?rid=5442977&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa415l065147v61x1%2F</link>
            <description>Content Type Journal ArticleCategory EditorialPages 1-3DOI 10.1007/s00401-011-0919-7Authors
		Eileen H. Bigio, Division of Neuropathology, Department of Pathology, Cognitive Neurology and Alzheimer Disease Center, Northwestern Feinberg School of Medicine, 710 N Fairbanks Ct, Olson 2-458, Chicago, IL 60611, USA
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5442977</comments>
            <pubDate>Sat, 19 Nov 2011 06:52:26 +0100</pubDate>
            <guid isPermaLink="false">5442977</guid>        </item>
        <item>
            <title>Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans</title>
            <link>http://www.medworm.com/index.php?rid=5432868&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg5304260k43p4321%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The pathologic phosphorylation and sub-cellular translocation of neuronal transactive response-DNA binding protein (TDP-43)
 was identified as the major disease protein in frontotemporal lobar degeneration (FTLD) with ubiquitinated inclusions, now
 termed FTLD-TDP, and amyotrophic lateral sclerosis (ALS). More recently, TDP-43 proteinopathy has been reported in dementia
 pugilistica or chronic traumatic encephalopathy caused by repetitive traumatic brain injury (TBI). While a single TBI has
 been linked to the development of Alzheimer’s disease and an increased frequency of neurofibrillary tangles, TDP-43 proteinopathy
 has not been examined with survival following a single TBI. Using immunohistochemistry specific for both pathological phosphorylated
 TDP-43 (p-TDP-43...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432868</comments>
            <pubDate>Fri, 18 Nov 2011 17:28:28 +0100</pubDate>
            <guid isPermaLink="false">5432868</guid>        </item>
        <item>
            <title>Mild cognitive impairment: pathology and mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5432870&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyt5j3j87612242t6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mild cognitive impairment (MCI) is rapidly becoming one of the most common clinical manifestations affecting the elderly.
 The pathologic and molecular substrate of people diagnosed with MCI is not well established. Since MCI is a human specific
 disorder and neither the clinical nor the neuropathological course appears to follow a direct linear path, it is imperative
 to characterize neuropathology changes in the brains of people who came to autopsy with a well-characterized clinical diagnosis
 of MCI. Herein, we discuss findings derived from clinical pathologic studies of autopsy cases who died with a clinical diagnosis
 of MCI. The heterogeneity of clinical MCI imparts significant challenges to any review of this subject. The pathologic substrate
 of MCI is equally c...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432870</comments>
            <pubDate>Fri, 18 Nov 2011 17:28:27 +0100</pubDate>
            <guid isPermaLink="false">5432870</guid>        </item>
        <item>
            <title>p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS</title>
            <link>http://www.medworm.com/index.php?rid=5432869&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F017n106343823208%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neuronal cytoplasmic inclusions (NCIs) containing phosphorylated TDP-43 (p-TDP-43) are the pathological hallmarks of motor
 neuron disease/amyotrophic lateral sclerosis (MND/ALS) and FTLD-TDP. The vast majority of NCIs in the brain and spinal cord
 also label for ubiquitin and p62, however, we have previously reported a subset of TDP-43 proteinopathy patients who have
 unusual and abundant p62 positive, TDP-43 negative inclusions in the cerebellum and hippocampus. Here we sought to determine
 whether these cases carry the hexanucleotide repeat expansion in C9orf72. Repeat primer PCR was performed in 36 MND/ALS, FTLD-MND/ALS and FTLD-TDP cases and four controls. Fourteen individuals with
 the repeat expansion were detected. In all the 14 expansion mutation cases there we...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432869</comments>
            <pubDate>Fri, 18 Nov 2011 17:28:27 +0100</pubDate>
            <guid isPermaLink="false">5432869</guid>        </item>
        <item>
            <title>Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer’s disease: implications for axoplasmic transport</title>
            <link>http://www.medworm.com/index.php?rid=5432871&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr4m12114268p1573%2F</link>
            <description>In this study we have investigated
 the distribution and the level of expression of kinesin light chains (KLCs) (responsible for binding of cargos during anterograde
 transport) and of dynein intermediate chain (DIC) (a component of the dynein complex during retrograde transport) in frontal
 cortex and cerebellar cortex of control subjects and Alzheimer’s disease patients. By immunoblotting, we found a significant
 decrease in the levels of expression of KLC1 and 2 and DIC in the frontal cortex, but not in the cerebellar cortex, of Alzheimer’s
 disease patients. A significant decrease in the levels of synaptophysin and of tubulin-β3 proteins, two neuronal markers,
 was also observed. KLC1 and DIC immunoreactivities did not co-localize with neurofibrillary tangles. The mean mRNA levels...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5432871</comments>
            <pubDate>Fri, 18 Nov 2011 06:53:47 +0100</pubDate>
            <guid isPermaLink="false">5432871</guid>        </item>
        <item>
            <title>Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting</title>
            <link>http://www.medworm.com/index.php?rid=5423713&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl13682j87852332r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The 2011 annual meeting of the Children’s Tumor Foundation, the annual gathering of the neurofibromatosis (NF) research and
 clinical communities, was attended by 330 participants who discussed integration of new signaling pathways into NF research,
 the appreciation for NF mutations in sporadic cancers, and an expanding pre-clinical and clinical agenda. NF1, NF2, and schwannomatosis
 collectively affect approximately 100,000 persons in US, and result from mutations in different genes. Benign tumors of NF1
 (neurofibroma and optic pathway glioma) and NF2 (schwannoma, ependymoma, and meningioma) and schwannomatosis (schwannoma)
 can cause significant morbidity, and there are no proven drug treatments for any form of NF. Each disorder is associated with
 additional mani...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5423713</comments>
            <pubDate>Tue, 15 Nov 2011 06:47:18 +0100</pubDate>
            <guid isPermaLink="false">5423713</guid>        </item>
        <item>
            <title>Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72</title>
            <link>http://www.medworm.com/index.php?rid=5410420&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr6815l27u2624r3p%2F</link>
            <description>In this study, we examined the neuropathology and clinical
 features of 20 cases of c9FTD/ALS from a brain bank for neurodegenerative disorders. Included are six patients clinically
 diagnosed with ALS, eight FTD, one FTD-MND and four Alzheimer-type dementia. Clinical information was unavailable for one
 patient. Pathologically, the cases all had TDP-43 pathology, but there were three major pathologic groups: ALS, FTLD-MND and
 FTLD-TDP. The ALS cases were morphologically similar to typical sporadic ALS with almost no extramotor TDP-43 pathology; all
 had oligodendroglial cytoplasmic inclusions. The FTLD-MND showed predominantly Mackenzie Type 3 TDP-43 pathology, and all
 had ALS-like pathology in motor neurons, but more extensive extramotor pathology, with oligodendroglial cytoplasmic inc...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410420</comments>
            <pubDate>Mon, 14 Nov 2011 16:52:47 +0100</pubDate>
            <guid isPermaLink="false">5410420</guid>        </item>
        <item>
            <title>An experimental rat model of sporadic Alzheimer’s disease and rescue of cognitive impairment with a neurotrophic peptide</title>
            <link>http://www.medworm.com/index.php?rid=5410421&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4t56218k5v64443%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer’s disease (AD) is multifactorial and, to date, no single cause of the sporadic form of this disease, which accounts
 for over 99% of the cases, has been established. In AD brain, protein phosphatase-2A (PP2A) activity is known to be compromised
 due to the cleavage and translocation of its potent endogenous inhibitor, I2PP2A, from the neuronal nucleus to the cytoplasm. Here, we show that adeno-associated virus vector-induced expression of the N-terminal
 I2NTF and C-terminal I2CTF halves of I2PP2A, also called SET, in brain reproduced key features of AD in Wistar rats. The I2NTF–CTF rats showed a decrease in brain PP2A activity, abnormal hyperphosphorylation and aggregation of tau, a loss of neuronal plasticity
 and impairment in spatial reference and work...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5410421</comments>
            <pubDate>Mon, 14 Nov 2011 16:52:46 +0100</pubDate>
            <guid isPermaLink="false">5410421</guid>        </item>
        <item>
            <title>Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5389884&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F458v700477303k30%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mitochondria are dynamic organelles which are essential for many cellular processes, such as ATP production by oxidative phosphorylation,
 lipid metabolism, assembly of iron sulfur clusters, regulation of calcium homeostasis, and cell death pathways. The dynamic
 changes in mitochondrial morphology, connectivity, and subcellular distribution are critically dependent on a highly regulated
 fusion and fission machinery. Mitochondrial function, dynamics, and quality control are vital for the maintenance of neuronal
 integrity. Indeed, there is mounting evidence that mitochondrial dysfunction plays a central role in several neurodegenerative
 diseases. In particular, the identification of genes linked to rare familial variants of Parkinson’s disease has fueled research
 o...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389884</comments>
            <pubDate>Sat, 05 Nov 2011 17:08:03 +0100</pubDate>
            <guid isPermaLink="false">5389884</guid>        </item>
        <item>
            <title>Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with loss of morphological but retained genetic key features during progression</title>
            <link>http://www.medworm.com/index.php?rid=5389883&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc5r810n023113x00%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-4DOI 10.1007/s00401-011-0903-2Authors
		Adelheid Woehrer, Institute of Neurology, Medical University of Vienna, Waehringer Guertel 18–20, 1097 Vienna, AustriaIrene Slavc, Department of Pediatrics, Medical University of Vienna, Vienna, AustriaAndreas Peyrl, Department of Pediatrics, Medical University of Vienna, Vienna, AustriaThomas Czech, Department of Neurosurgery, Medical University of Vienna, Vienna, AustriaChristian Dorfer, Department of Neurosurgery, Medical University of Vienna, Vienna, AustriaDaniela Prayer, Department of Radiology, Medical University of Vienna, Vienna, AustriaSusanne Stary, Department of Pathology, Medical University of Vienna, Vienna, AustriaBerthold Streubel, Department of Pathology, Medical Universi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389883</comments>
            <pubDate>Sat, 05 Nov 2011 17:08:03 +0100</pubDate>
            <guid isPermaLink="false">5389883</guid>        </item>
        <item>
            <title>Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples</title>
            <link>http://www.medworm.com/index.php?rid=5389885&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk28q17p0226401mw%2F</link>
            <description>We present an assay based on nanoString technology
 that is capable of rapidly, reliably, and reproducibly assigning clinical FFPE medulloblastoma samples to their molecular
 subgroup, and which is highly suited for future medulloblastoma clinical trials.
 
 
	Content Type Journal ArticleCategory Methods PaperPages 1-12DOI 10.1007/s00401-011-0899-7Authors
		Paul A. Northcott, The Arthur and Sonia Labatt Brain Tumour Research Center, Hospital for Sick Children, Toronto, ON, CanadaDavid J. H. Shih, The Arthur and Sonia Labatt Brain Tumour Research Center, Hospital for Sick Children, Toronto, ON, CanadaMarc Remke, Division Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, GermanyYoon-Jae Cho, Department of Neurology, Children’s Hospital Boston, Boston, MA, USAMarcel Kool...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389885</comments>
            <pubDate>Sat, 05 Nov 2011 17:08:02 +0100</pubDate>
            <guid isPermaLink="false">5389885</guid>        </item>
        <item>
            <title>Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy</title>
            <link>http://www.medworm.com/index.php?rid=5389886&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38uq54q281720976%2F</link>
            <description>We describe in detail the histopathology of IRIS in natalizumab-associated PML.
 PML–IRIS, ongoing PML infection, and MS exacerbation may be impossible to discern clinically alone. MRI may provide some clues
 for distinguishing different pathologies that can be differentiated histologically. In our individual cases, biopsy helped
 to clarify diagnoses in natalizumab-associated PML.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-11DOI 10.1007/s00401-011-0900-5Authors
		Imke Metz, Department of Neuropathology, University Medical Center, Georg August University Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, GermanyErnst-Wilhelm Radue, Medical Image Analysis Center (MIAC), University Hospital Basel, Basel, SwitzerlandAgustin Oterino, Service of Neurology, University Hosp...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389886</comments>
            <pubDate>Sat, 05 Nov 2011 17:08:01 +0100</pubDate>
            <guid isPermaLink="false">5389886</guid>        </item>
        <item>
            <title>Selective tau tyrosine nitration in non-AD tauopathies</title>
            <link>http://www.medworm.com/index.php?rid=5389887&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fagur145475010236%2F</link>
            <description>In this report, we examined whether tau nitration at these sites
 also occurs in corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and Pick’s disease (PiD), three neurodegenerative
 tauopathies that contain abundant tau deposits within glial and neuronal cell types but lack amyloid deposition. The reactivity
 of these antibodies was also compared to two previously characterized antibodies Tau-nY18 and Tau-nY29, specific for tau nitrated
 at tyrosine 18 and tyrosine 29, respectively. In the present experiments, Tau-nY18 did not label the classical pathological
 lesions of CBD or PSP but did label the neuronal lesions associated with PiD to a limited extent. In contrast, Tau-nY29 revealed
 some, but not all classes of tau inclusions associated with both CBD and PSP but ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5389887</comments>
            <pubDate>Sat, 05 Nov 2011 17:08:00 +0100</pubDate>
            <guid isPermaLink="false">5389887</guid>        </item>
        <item>
            <title>Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application</title>
            <link>http://www.medworm.com/index.php?rid=5365403&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq49321905672435g%2F</link>
            <description>In conclusion, we report multiple lines of evidence that Fas/FasL activation plays a
 pivotal role in mediating apoptosis, the inflammatory response and neurodegeneration after SCI, providing a compelling rationale
 for therapeutically targeting Fas in human SCI.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-15DOI 10.1007/s00401-011-0882-3Authors
		Wen Ru Yu, Division of Genetics and Development, Toronto Western Research Institute and Krembil Neuroscience Centre, Toronto Western Hospital, University Health Network, Toronto, ON M5T 2S8, CanadaMichael G. Fehlings, Division of Neurosurgery, Toronto Western Research Institute and Krembil Neuroscience Centre, The Toronto Western Hospital, University Health Network, Room 4W-449, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada
...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365403</comments>
            <pubDate>Sat, 29 Oct 2011 05:50:22 +0100</pubDate>
            <guid isPermaLink="false">5365403</guid>        </item>
        <item>
            <title>Inner ear lesions in congenital cytomegalovirus infection of human fetuses</title>
            <link>http://www.medworm.com/index.php?rid=5365404&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1677532115m2825%2F</link>
            <description>This study documenting infection of
 the structures involved in endolymph secretion and potassium homeostasis in fetuses with high amniotic fluid viral loads suggests
 that potassium dysregulation in the endolymphatic compartment of the inner ear may lead to secondary degeneration of the sensory
 structures. In addition, the occurrence of SNHL depends on the intensity and duration of the viral infection and inflammation.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-12DOI 10.1007/s00401-011-0895-yAuthors
		Natacha Teissier, Pediatric ENT Department, Robert Debré Hospital, APHP, Paris, FranceAnne-Lise Delezoide, Department of Developmental Biology, Robert Debré Hospital, APHP, Paris, FranceAnne-Elisabeth Mas, Department of Pathology, Béclère Hospital, APHP, Clamart, Fr...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365404</comments>
            <pubDate>Fri, 28 Oct 2011 05:49:06 +0100</pubDate>
            <guid isPermaLink="false">5365404</guid>        </item>
        <item>
            <title>Multinodular leptomeningeal metastases from ETANTR contain both small blue cell and maturing neuropil elements</title>
            <link>http://www.medworm.com/index.php?rid=5365405&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4w1m151347m25k26%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-3DOI 10.1007/s00401-011-0894-zAuthors
		B. K. Kleinschmidt-DeMasters, Department of Pathology, UCHSC, University of Colorado at Denver, Anschutz Medical Campus, 12605 E. 16th Avenue, MS F768, Aurora, CO 80045, USAArianne Boylan, Department of Pathology, UCHSC, University of Colorado at Denver, Anschutz Medical Campus, 12605 E. 16th Avenue, MS F768, Aurora, CO 80045, USAKelley Capocelli, Department of Pathology, Children’s Hospital Colorado, 13123 E. 16th Avenue, Aurora, CO 80045, USAPhilip J. Boyer, Department of Pathology, UCHSC, University of Colorado at Denver, Anschutz Medical Campus, 12605 E. 16th Avenue, MS F768, Aurora, CO 80045, USANicholas K. Foreman, Department of Neurooncology, Children’s Hospital Colorado, 13123 E...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365405</comments>
            <pubDate>Fri, 28 Oct 2011 05:49:05 +0100</pubDate>
            <guid isPermaLink="false">5365405</guid>        </item>
        <item>
            <title>Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach</title>
            <link>http://www.medworm.com/index.php?rid=5365406&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk8496xjn4211g147%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In sporadic Alzheimer’s disease (AD), neurofibrillary lesion formation is preceded by extensive post-translational modification
 of the microtubule associated protein tau. To identify the modification signature associated with tau lesion formation at
 single amino acid resolution, immunopurified paired helical filaments were isolated from AD brain and subjected to nanoflow
 liquid chromatography–tandem mass spectrometry analysis. The resulting spectra identified monomethylation of lysine residues
 as a new tau modification. The methyl-lysine was distributed among seven residues located in the projection and microtubule
 binding repeat regions of tau protein, with one site, K254, being a substrate for a competing lysine modification, ubiquitylation.
 To characterize ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5365406</comments>
            <pubDate>Fri, 28 Oct 2011 05:49:03 +0100</pubDate>
            <guid isPermaLink="false">5365406</guid>        </item>
        <item>
            <title>Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus</title>
            <link>http://www.medworm.com/index.php?rid=5349690&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F117848tj671473h3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer’s disease (AD).
 In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old)
 PS1M146L/APP751SL mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques
 accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction
 of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the
 axonal dystrophies, and by electron microscopic identification of numerous autophagic vesicles filling and causing the axonal
 swellings. Ea...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349690</comments>
            <pubDate>Fri, 21 Oct 2011 16:00:19 +0100</pubDate>
            <guid isPermaLink="false">5349690</guid>        </item>
        <item>
            <title>Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=5349692&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp07m2828145653t6%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-2DOI 10.1007/s00401-011-0891-2Authors
		Manuel Montesinos-Rongen, Department of Neuropathology, University Hospital of Cologne, Cologne, GermanyElzbieta Godlewska, Department of Neuropathology, University Hospital of Cologne, Cologne, GermanyAnna Brunn, Department of Neuropathology, University Hospital of Cologne, Cologne, GermanyOtmar D. Wiestler, German Cancer Research Center, Heidelberg, GermanyReiner Siebert, Institute of Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, GermanyMartina Deckert, Department of Neuropathology, University Hospital of Cologne, Cologne, Germany
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349692</comments>
            <pubDate>Fri, 21 Oct 2011 16:00:17 +0100</pubDate>
            <guid isPermaLink="false">5349692</guid>        </item>
        <item>
            <title>Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex</title>
            <link>http://www.medworm.com/index.php?rid=5349691&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg507p3whj8202577%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The apolipoprotein E4 allele (APOE4) contributes to Alzheimer’s disease (AD) risk and APOE2 is protective, but the relevant cellular mechanisms are unknown. We have used flow cytometry analysis to measure apolipoprotein
 E (apoE) and amyloid beta peptide (Aβ) levels in large populations of synaptic terminals from AD and aged cognitively normal
 controls, and demonstrate that modest but significant increases in soluble apoE levels accompany elevated Aβ in AD cortical
 synapses and in an APP/PS1 rat model of AD. Dual labeling experiments document co-localization of apoE and Aβ in individual
 synapses with concentration of Aβ in a small population of apoE-positive synapses in both AD and controls. Consistent with
 a clearance role, the apoE level was higher in Aβ-po...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5349691</comments>
            <pubDate>Fri, 21 Oct 2011 16:00:17 +0100</pubDate>
            <guid isPermaLink="false">5349691</guid>        </item>
        <item>
            <title>A proteomic study identifies different levels of light chain ferritin in corticobasal degeneration and progressive supranuclear palsy</title>
            <link>http://www.medworm.com/index.php?rid=5338124&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff47222722j437736%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Clinical and pathological evidence supports the notion that corticobasal degeneration (CBD) and progressive supranuclear palsy
 (PSP) are distinct, but overlapping neurodegenerative tauopathies. Although both disorders are characterized by abnormal accumulation
 of 4-repeat tau, they display distinct proteolytic profiles of tau species and they have distinct astrocytic lesions, astrocytic
 plaques in CBD and tufted astrocytes in PSP. To investigate other differences between these two disorders at the molecular
 level, we compared the profiles of proteins from caudate nucleus of CBD and PSP by quantitative two-dimensional difference
 gel electrophoresis. Twenty-one protein spots differentially expressed in CBD and PSP were dissected for mass spectrometry
 (MS). One of th...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338124</comments>
            <pubDate>Wed, 19 Oct 2011 15:44:25 +0100</pubDate>
            <guid isPermaLink="false">5338124</guid>        </item>
        <item>
            <title>Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases</title>
            <link>http://www.medworm.com/index.php?rid=5338123&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpq5531674827786n%2F</link>
            <description>In conclusion, expression of BRAF V600E mutant protein occurs in approximately 6% of BM and is consistent in different
 tumor manifestations of the same patient. Thus, BRAF V600E inhibiting therapies seem feasible in selected BM patients. Immunohistochemical
 visualization of V600E-mutant BRAF protein is a promising tool for patient stratification. An integrated approach combining
 both, VE1 immunohistochemistry and genetic analysis may increase the diagnostic accuracy of BRAF mutation analysis.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-11DOI 10.1007/s00401-011-0887-yAuthors
		David Capper, Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Im Neuenheimer Feld 220/221, 69120 Heidelberg, GermanyAnna Sophie Berghoff, Department of Medicine ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338123</comments>
            <pubDate>Wed, 19 Oct 2011 15:44:25 +0100</pubDate>
            <guid isPermaLink="false">5338123</guid>        </item>
        <item>
            <title>Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination</title>
            <link>http://www.medworm.com/index.php?rid=5338125&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm316582061827g30%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Brain-derived neurotrophic factor (BDNF) is involved in neuronal and glial development and survival. While neurons and astrocytes
 are its main cellular source in the central nervous system (CNS), bioactive BDNF is also expressed in immune cells and in
 lesions of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (EAE). Previous data revealed
 that BDNF exerts neuroprotective effects in myelin oligodendrocyte glycoprotein-induced EAE. Using a conditional knock-out
 model with inducible deletion of BDNF, we here show that clinical symptoms and structural damage are increased when BDNF is
 absent during the initiation phase of clinical EAE. In contrast, deletion of BDNF later in the disease course of EAE did not
 result in significant chang...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338125</comments>
            <pubDate>Wed, 19 Oct 2011 05:54:45 +0100</pubDate>
            <guid isPermaLink="false">5338125</guid>        </item>
        <item>
            <title>Neuropathological subtypes of Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5338126&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F53579r2l1352w328%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-2DOI 10.1007/s00401-011-0889-9Authors
		Kurt A. Jellinger, Institute of Clinical Neurobiology, Kenyongasse 18, 1070 Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5338126</comments>
            <pubDate>Tue, 18 Oct 2011 15:56:09 +0100</pubDate>
            <guid isPermaLink="false">5338126</guid>        </item>
        <item>
            <title>Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor</title>
            <link>http://www.medworm.com/index.php?rid=5325364&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbk820452206241p4%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-3DOI 10.1007/s00401-011-0886-zAuthors
		Benjamin Ellezam, Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USABrett J. Theeler, Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USARajyalakshmi Luthra, Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USAAdekunle M. Adesina, Department of Pathology, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX, USAKenneth D. Aldape, Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USAMark R. Gilbert, Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
	

	
		Journal Acta Neuropatho...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5325364</comments>
            <pubDate>Thu, 13 Oct 2011 15:50:18 +0100</pubDate>
            <guid isPermaLink="false">5325364</guid>        </item>
        <item>
            <title>Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis</title>
            <link>http://www.medworm.com/index.php?rid=5316864&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmn2x0g3n44u81438%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), loss of the blood–brain barrier
 (BBB) tight junction (TJ) protein claudin-3 correlates with immune cell infiltration into the CNS and BBB leakiness. Here
 we show that sealing BBB TJs by ectopic tetracycline-regulated expression of the TJ protein claudin-1 in Tie-2 tTA//TRE-claudin-1
 double transgenic C57BL/6 mice had no influence on immune cell trafficking across the BBB during EAE and furthermore did not
 influence the onset and severity of the first clinical disease episode. However, expression of claudin-1 did significantly
 reduce BBB leakiness for both blood borne tracers and endogenous plasma proteins specifically around vessels expressing claudin-1.
 In addition,...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316864</comments>
            <pubDate>Sat, 08 Oct 2011 15:44:51 +0100</pubDate>
            <guid isPermaLink="false">5316864</guid>        </item>
        <item>
            <title>Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma</title>
            <link>http://www.medworm.com/index.php?rid=5316865&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb6m6610416w014g3%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-2DOI 10.1007/s00401-011-0885-0Authors
		Jens Schittenhelm, Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tubingen, Tübingen, GermanyMichel Mittelbronn, Neurological Institute, Edinger Institute, University of Frankfurt, Frankfurt, GermanyRichard Meyermann, Department of Neuropathology, Institute of Pathology and Neuropathology, University of Tubingen, Tübingen, GermanyArthur Melms, Department of Neurology, University of Tubingen, Tübingen, GermanyMarcos Tatagiba, Department of Neurosurgery, University of Tubingen, Tübingen, GermanyDavid Capper, Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany
	

	
		Journal Acta Neuropathol...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5316865</comments>
            <pubDate>Sat, 08 Oct 2011 05:51:50 +0100</pubDate>
            <guid isPermaLink="false">5316865</guid>        </item>
        <item>
            <title>Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region</title>
            <link>http://www.medworm.com/index.php?rid=5298200&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1214621w81tu886%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;GABAergic interneurons synchronize network activities and monitor information flow. Post-mortem studies have reported decreased
 densities of cortical interneurons in schizophrenia (SZ) and bipolar disorder (BPD). The entorhinal cortex (EC) and the adjacent
 subicular regions are a hub for integration of hippocampal and cortical information, a process that is disrupted in SZ. Here
 we contrast and compare the density of interneuron populations in the caudal EC and subicular regions in BPD type I (BPD-I),
 SZ, and normal control (NC) subjects. Post-mortem human parahippocampal specimens of 13 BPD-I, 11 SZ and 17 NC subjects were
 used to examine the numerical density of parvalbumin-, somatostatin- or calbindin-positive interneurons. We observed a reduction
 in the numeri...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298200</comments>
            <pubDate>Tue, 04 Oct 2011 05:50:24 +0100</pubDate>
            <guid isPermaLink="false">5298200</guid>        </item>
        <item>
            <title>Homeostatic responses by surviving cortical pyramidal cells in neurodegenerative tauopathy</title>
            <link>http://www.medworm.com/index.php?rid=5298201&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx55586w236w0p1q1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cortical neuron death is prevalent by 9&amp;nbsp;months in rTg(tauP301L)4510 tau mutant mice (TG) and surviving pyramidal cells exhibit dendritic regression and spine loss. We used whole-cell patch-clamp
 recordings to investigate the impact of these marked structural changes on spontaneous excitatory and inhibitory postsynaptic
 currents (sEPSCs and sIPSCs) of layer 3 pyramidal cells in frontal cortical slices from behaviorally characterized TG and
 non-transgenic (NT) mice at this age. Frontal lobe function of TG mice was intact following a short delay interval but impaired
 following a long delay interval in an object recognition test, and cortical atrophy and cell loss were pronounced. Surviving
 TG cells had significantly reduced dendritic diameters, total spine densit...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298201</comments>
            <pubDate>Tue, 04 Oct 2011 05:50:23 +0100</pubDate>
            <guid isPermaLink="false">5298201</guid>        </item>
        <item>
            <title>TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype</title>
            <link>http://www.medworm.com/index.php?rid=5298202&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Few0341tg86n8x245%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;TDP-43 immunoreactive (TDP-43-ir) pathological changes were investigated in the temporal cortex and hippocampus of 11 patients
 with autosomal dominant familial forms of Alzheimer’s disease (FAD), 169 patients with sporadic AD [85 with early onset disease
 (EOAD) (i.e before 65&amp;nbsp;years of age), and 84 with late onset after this age (LOAD)], 50 individuals with Down’s Syndrome (DS)
 and 5 patients with primary hippocampal sclerosis (HS). TDP-43-ir pathological changes were present, overall, in 34/180 of
 AD cases. They were present in 1/11 (9%) FAD, and 9/85 (10%) EOAD patients but were significantly more common (p&amp;nbsp;=&amp;nbsp;0.003) in LOAD where 24/84 (29%) patients showed such changes. There were no demographic differences, other than onset
 age, between AD pat...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5298202</comments>
            <pubDate>Tue, 04 Oct 2011 05:50:21 +0100</pubDate>
            <guid isPermaLink="false">5298202</guid>        </item>
        <item>
            <title>Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases</title>
            <link>http://www.medworm.com/index.php?rid=5287454&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj42116235443j803%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Risks associated with brain biopsy limit availability of tissues and the role of brain biopsy in diagnosing neurodegeneration
 is unclear. We developed a simulated brain biopsy paradigm to comprehensively evaluate potential accuracy of detecting neurodegeneration
 in biopsies. Postmortem tissue from the frontal, temporal and parietal cortices and basal ganglia from 73 cases including
 Alzheimer’s disease (AD), Lewy body disease (LBD), frontotemporal lobar degeneration-TDP43 (FTLD-TDP), multiple system atrophy
 (MSA), Pick’s disease (PiD), corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) were evaluated using
 H&amp;E and immunostains. Brain biopsy was simulated in a blinded manner by masking each slide with opaque tape except for an
 area measurin...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287454</comments>
            <pubDate>Fri, 30 Sep 2011 05:53:13 +0100</pubDate>
            <guid isPermaLink="false">5287454</guid>        </item>
        <item>
            <title>Opportunities and challenges in developing Alzheimer disease therapeutics</title>
            <link>http://www.medworm.com/index.php?rid=5287455&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr372542245447q65%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Alzheimer disease (AD) is a chronic, progressive disorder with an average disease progression of 7–10&amp;nbsp;years. However, the
 histopathological hallmark lesions of this disease, the extracellular Aβ plaques and the intraneuronal neurofibrillary tangles,
 start as early as childhood in the affected individuals. AD is multifactorial and probably involves many different etiopathogenic
 mechanisms. Thus, while AD offers a wide window of opportunity that practically includes the whole life span of the affected
 individuals, and numerous therapeutic targets, the multifactorial nature of this disease also makes the selection of the therapeutic
 targets an immensely challenging task. In addition to β-amyloidosis and neurofibrillary degeneration, the AD brain also is
 comp...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5287455</comments>
            <pubDate>Fri, 30 Sep 2011 05:53:11 +0100</pubDate>
            <guid isPermaLink="false">5287455</guid>        </item>
        <item>
            <title>The “Shaken Baby” syndrome: pathology and mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5262589&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4810772lkkg31410%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The “Shaken Baby” syndrome (SBS) is the subject of intense controversy; the diagnosis has in the past depended on the triad
 of subdural haemorrhage (SDH), retinal haemorrhage and encephalopathy. While there is no doubt that infants do suffer abusive
 injury at the hands of their carers and that impact can cause catastrophic intracranial damage, research has repeatedly undermined
 the hypothesis that shaking per se can cause this triad. The term non-accidental head injury has therefore been widely adopted.
 This review will focus on the pathology and mechanisms of the three physiologically associated findings which constitute the
 “triad” and are seen in infants suffering from a wide range of non-traumatic as well as traumatic conditions. “Sub” dural
 bleedi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5262589</comments>
            <pubDate>Sat, 24 Sep 2011 05:43:16 +0100</pubDate>
            <guid isPermaLink="false">5262589</guid>        </item>
        <item>
            <title>Paraneoplastic encephalomyelopathies: pathology and mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5252073&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft106822313578t0j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The last three decades have seen major advances in the understanding of paraneoplastic and idiopathic autoimmune disorders
 affecting the central nervous system (CNS). Neural-specific autoantibodies and their target antigens have been discovered,
 immunopathology and neuroimaging patterns recognized and pathogenic mechanisms elucidated. Disorders accompanied by autoantibody
 markers of neural peptide-specific cytotoxic effector T cells [such as anti-neuronal nuclear antibody type 1 (ANNA-1, aka
 anti-Hu), Purkinje cell antibody type 1 (PCA-1, aka anti-Yo) and CRMP-5 IgG] are generally poorly responsive to immunotherapy.
 Disorders accompanied by neural plasma membrane-reactive autoantibodies [the effectors of synaptic disorders, which include
 antibodies targeting volta...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5252073</comments>
            <pubDate>Thu, 22 Sep 2011 06:38:59 +0100</pubDate>
            <guid isPermaLink="false">5252073</guid>        </item>
        <item>
            <title>Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis</title>
            <link>http://www.medworm.com/index.php?rid=5252074&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe1r242un1722211u%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intra-muscle fiber accumulation of ubiquitinated protein aggregates containing several conformationally modified proteins,
 including amyloid-β and phosphorylated tau, is characteristic of the pathologic phenotype of sporadic inclusion-body myositis
 (s-IBM), the most common progressive degenerative myopathy of older persons. Abnormalities of protein-degradation, involving
 both the 26S proteasome and autophagic-lysosomal pathways, were previously demonstrated in s-IBM muscle. NBR1 is a ubiquitin-binding
 scaffold protein importantly participating in autophagic degradation of ubiquitinated proteins. Whereas abnormalities of p62,
 a ubiquitin-binding protein, were previously described in s-IBM, abnormalities of NBR1 have not been reported in s-IBM. We
 have now identifi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5252074</comments>
            <pubDate>Tue, 20 Sep 2011 15:45:54 +0100</pubDate>
            <guid isPermaLink="false">5252074</guid>        </item>
        <item>
            <title>Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response</title>
            <link>http://www.medworm.com/index.php?rid=5252075&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwl0479h3523512u7%2F</link>
            <description>In conclusion, GVD affects neurons in a hierarchical
 sequence that allows the distinction of five stages. The topographic distribution of GVD restricted to regions involved in
 response to chronic stress could indicate a link between GVD and chronically stressful influences. Moreover, the association
 of the GVD stages with those of AD-related pathology but not with other neurodegenerative disorders points to a possible role
 of GVD and the response to chronic stress in the pathogenesis of AD.
 
 
	Content Type Journal ArticleCategory Original PaperPages 1-13DOI 10.1007/s00401-011-0871-6Authors
		Dietmar Rudolf Thal, Laboratory of Neuropathology, Institute of Pathology, Center for Clinical Research, University of Ulm, Ulm, GermanyKelly Del Tredici, Department of Neurology, University of U...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5252075</comments>
            <pubDate>Tue, 20 Sep 2011 15:45:53 +0100</pubDate>
            <guid isPermaLink="false">5252075</guid>        </item>
        <item>
            <title>Complex tauopathies versus tangle predominant dementia</title>
            <link>http://www.medworm.com/index.php?rid=5252076&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F192r87p052557677%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-1DOI 10.1007/s00401-011-0868-1Authors
		Kurt A. Jellinger, Institute of Clinical Neurobiology, Kenyongasse 18, 1070 Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5252076</comments>
            <pubDate>Tue, 20 Sep 2011 05:51:00 +0100</pubDate>
            <guid isPermaLink="false">5252076</guid>        </item>
        <item>
            <title>Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery</title>
            <link>http://www.medworm.com/index.php?rid=5239944&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw7772x1023008456%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Melanocortins produce neuroprotection against ischemic stroke with subsequent long-lasting functional recovery, through melanocortin
 MC4 receptor activation. Here we investigated whether the long-lasting beneficial effect of melanocortins in stroke conditions
 is associated with a stimulation of neurogenesis. Gerbils were subjected to transient global cerebral ischemia by occluding
 both common carotid arteries for 10&amp;nbsp;min; then, they were prepared for 5-bromo-2′-deoxyuridine (BrdU) labeling of proliferating
 cells. Delayed treatment (up to 9&amp;nbsp;h after the ischemic injury) for 11&amp;nbsp;days with the melanocortin analog [Nle4,d-Phe7]α-melanocyte-stimulating hormone (NDP-α-MSH) improved learning and memory throughout the 50-day observation period. Immunohistoch...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5239944</comments>
            <pubDate>Sat, 17 Sep 2011 05:49:06 +0100</pubDate>
            <guid isPermaLink="false">5239944</guid>        </item>
        <item>
            <title>Cribriform neuroepithelial tumour: novel clinicopathological, ultrastructural and cytogenetic findings</title>
            <link>http://www.medworm.com/index.php?rid=5228079&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn472014767u5464l%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-4DOI 10.1007/s00401-011-0872-5Authors
		George M. Ibrahim, Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, CanadaAnnie Huang, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, CanadaWilliam Halliday, Division of Pathology, The Hospital for Sick Children, Toronto, ON, CanadaPeter B. Dirks, Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, CanadaDavid Malkin, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, CanadaBerivan Baskin, Division of Molecular Genetics, The Hospital for Sick Children, Toronto, ON, CanadaMary Shago, Division of Molecular Genetics, The Hospital for Sick Children, Toronto, ON, CanadaCynthia Hawkins, Division o...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228079</comments>
            <pubDate>Thu, 15 Sep 2011 05:53:52 +0100</pubDate>
            <guid isPermaLink="false">5228079</guid>        </item>
        <item>
            <title>Effect of ionizing radiation in sensory ganglion neurons: organization and dynamics of nuclear compartments of DNA damage/repair and their relationship with transcription and cell cycle</title>
            <link>http://www.medworm.com/index.php?rid=5228080&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F94v22084q3633746%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Neurons are very sensitive to DNA damage induced by endogenous and exogenous genotoxic agents, as defective DNA repair can
 lead to neurodevelopmental disorders, brain tumors and neurodegenerative diseases with severe clinical manifestations. Understanding
 the impact of DNA damage/repair mechanisms on the nuclear organization, particularly on the regulation of transcription and
 cell cycle, is essential to know the pathophysiology of defective DNA repair syndromes. In this work, we study the nuclear
 architecture and spatiotemporal organization of chromatin compartments involved in the DNA damage response (DDR) in rat sensory
 ganglion neurons exposed to X-ray irradiation (IR). We demonstrate that the neuronal DDR involves the formation of two categories
 of DNA-damage...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228080</comments>
            <pubDate>Wed, 14 Sep 2011 05:44:09 +0100</pubDate>
            <guid isPermaLink="false">5228080</guid>        </item>
        <item>
            <title>Complex tauopathies vs. tangle predominant dementia</title>
            <link>http://www.medworm.com/index.php?rid=5228081&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq727218x6472u78j%2F</link>
            <description>Content Type Journal ArticleCategory CorrespondencePages 1-1DOI 10.1007/s00401-011-0870-7Authors
		Gabor G. Kovacs, Institute of Neurology, Medical University Vienna, AKH 4J, Währinger Gürtel 18-20, 1097 Vienna, AustriaHerbert Budka, Institute of Neurology, Medical University Vienna, AKH 4J, Währinger Gürtel 18-20, 1097 Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5228081</comments>
            <pubDate>Wed, 14 Sep 2011 05:44:08 +0100</pubDate>
            <guid isPermaLink="false">5228081</guid>        </item>
        <item>
            <title>Age-related loss of calcium buffering and selective neuronal vulnerability in Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=5171261&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh48844220t405323%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The reasons for the selective vulnerability of distinct neuronal populations in neurodegenerative disorders are unknown. The
 cholinergic neurons of the basal forebrain are vulnerable to pathology and loss early in Alzheimer’s disease and in a number
 of other neurodegenerative disorders of the elderly. In the primate, including man, these neurons are rich in the calcium
 buffer calbindin-D28K. Here, we confirm that these neurons undergo a substantial loss of calbindin in the course of normal aging and report a further
 loss of calbindin in Alzheimer’s disease both at the level of RNA and protein. Significantly, cholinergic neurons that had
 lost their calbindin in the course of normal aging were those that selectively degenerated in Alzheimer’s disease. Furthermo...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5171261</comments>
            <pubDate>Fri, 26 Aug 2011 16:17:09 +0100</pubDate>
            <guid isPermaLink="false">5171261</guid>        </item>
        <item>
            <title>A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat</title>
            <link>http://www.medworm.com/index.php?rid=5164379&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1k315lv50525634%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Incompletely resectable ependymomas are associated with poor prognosis despite intensive radio- and chemotherapy. Novel treatments
 have been difficult to develop due to the lack of appropriate models. Here, we report on the generation of a high-risk cytogenetic
 group&amp;nbsp;3 and molecular group&amp;nbsp;C ependymoma model (DKFZ-EP1NS) which is based on primary ependymoma cells obtained from a patient
 with metastatic disease. This model displays stem cell features such as self-renewal capacity, differentiation capacity, and
 specific marker expression. In&amp;nbsp;vivo transplantation showed high tumorigenic potential of these cells, and xenografts phenotypically
 recapitulated the original tumor in a niche-dependent manner. DKFZ-EP1NS cells harbor transcriptome plasticity, en...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164379</comments>
            <pubDate>Tue, 23 Aug 2011 15:52:56 +0100</pubDate>
            <guid isPermaLink="false">5164379</guid>        </item>
        <item>
            <title>Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma</title>
            <link>http://www.medworm.com/index.php?rid=5164380&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4723254hj7q18h20%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Glioblastoma (GBM) is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival
 outcomes. The mechanisms of radioresistance are not completely understood. However, cancer cells with an immature stem-like
 phenotype are hypothesised to play a role in radioresistance. Since the progenitor marker neuron-glial-2 (NG2) has been shown
 to regulate several aspects of GBM progression in experimental systems, we hypothesised that its expression would influence
 the survival of GBM patients. Quantification of NG2 expression in 74 GBM biopsies from newly diagnosed and untreated patients
 revealed that 50% express high NG2 levels on tumour cells and associated vessels, being associated with significantly shorter
 survival. This eff...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5164380</comments>
            <pubDate>Tue, 23 Aug 2011 15:52:55 +0100</pubDate>
            <guid isPermaLink="false">5164380</guid>        </item>
        <item>
            <title>Microglial pathology in Down syndrome</title>
            <link>http://www.medworm.com/index.php?rid=5147697&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu0p3286663831302%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Subjects with Down syndrome (DS) inevitably develop histopathological features pathognomonic of Alzheimer’s disease (AD),
 and DS can therefore be considered a human model of AD. Similar to AD, microglial activation has been reported in DS and the
 idea that detrimental neuroinflammation plays a key role in the pathogenesis of neurodegeneration is firmly embedded. However,
 recent work from this laboratory has offered evidence for an alternative view regarding the role of microglial cells in AD
 pathogenesis by showing presence of dystrophic (senescent) rather than activated microglia in both the AD and DS brain. In
 this report, we build on previously published observations in human brain and offer a detailed analysis of microglial senescent
 pathology in the tempora...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5147697</comments>
            <pubDate>Wed, 17 Aug 2011 05:56:50 +0100</pubDate>
            <guid isPermaLink="false">5147697</guid>        </item>
        <item>
            <title>Transportin1: a marker of FTLD-FUS</title>
            <link>http://www.medworm.com/index.php?rid=5147698&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjq548057701527n4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The term frontotemporal lobar degeneration (FTLD) describes a group of disorders that are subdivided by the presence of one
 of a number of pathological proteins identified in the inclusion bodies observed post-mortem. The FUS variant is defined by
 the presence of the fused in sarcoma protein (FUS) in the pathological inclusions. However, similar to other FTLDs, the disease
 pathogenesis of FTLD-FUS remains largely poorly understood. Here we present data that the protein transportin1 (TRN1) is abundant
 in the FUS-positive inclusions. TRN1, the protein product of the TNP01 gene, is responsible for shuttling proteins containing
 an M9 nuclear localisation signal between the nuclear and cytoplasmic compartments. RNA interacting proteins, including FUS,
 have been implica...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5147698</comments>
            <pubDate>Wed, 17 Aug 2011 05:56:49 +0100</pubDate>
            <guid isPermaLink="false">5147698</guid>        </item>
        <item>
            <title>Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology</title>
            <link>http://www.medworm.com/index.php?rid=5121132&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6568806843k0231%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00401-011-0862-7Authors
		Yasuko Toyoshima, Department of Pathology, Brain Research Institute, University of Niigata, 1-757 Asahimachi, Chuo-ku, Niigata 951-8585, JapanHajime Tanaka, Department of Neurology, Shinrakuen Hospital, Niigata, JapanMitsuteru Shimohata, Department of Neurology, Shinrakuen Hospital, Niigata, JapanKakuhei Kimura, Department of Pathology, Shinrakuen Hospital, Niigata, JapanTakashi Morita, Department of Pathology, Shinrakuen Hospital, Niigata, JapanAkiyoshi Kakita, Department of Pathology, Brain Research Institute, University of Niigata, 1-757 Asahimachi, Chuo-ku, Niigata 951-8585, JapanHitoshi Takahashi, Department of Pathology, Brain Research Institute, University of Niigata, 1-757 Asahimachi, Chuo-ku, Niigata 951...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5121132</comments>
            <pubDate>Wed, 10 Aug 2011 15:49:28 +0100</pubDate>
            <guid isPermaLink="false">5121132</guid>        </item>
        <item>
            <title>Erratum to: Intravascular mucinosis: a rare cause of cerebral infarction</title>
            <link>http://www.medworm.com/index.php?rid=5111382&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F380t308768641820%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00401-011-0859-2Authors
		Marie Christine Bernardo, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USAJonathan Graff-Radford, Department of Neurology, Mayo Clinic, Rochester, MN, USAJoshua Menke, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USAChristopher Hallemeier, Department of Neurology, Mayo Clinic, Rochester, MN, USAChristopher J. Boes, Department of Neurology, Mayo Clinic, Rochester, MN, USAMark Lewis, Department of Neurology, Mayo Clinic, Rochester, MN, USABernd Scheithauer, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USACaterina Giannini, Department of Labo...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5111382</comments>
            <pubDate>Sat, 06 Aug 2011 05:52:52 +0100</pubDate>
            <guid isPermaLink="false">5111382</guid>        </item>
        <item>
            <title>Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI</title>
            <link>http://www.medworm.com/index.php?rid=5089700&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa2g136nt0742218r%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Previous studies of Aβ plasma as a biomarker for Alzheimer’s disease (AD) obtained conflicting results. We here included 715
 subjects with baseline Aβ1-40 and Aβ1-42 plasma measurement (50% with 4 serial annual measurements): 205 cognitively normal controls (CN), 348 patients mild cognitive
 impairment (MCI) and 162 with AD. We assessed the factors that modified their concentrations and correlated these values with
 PIB PET, MRI and tau and Aβ1-42 measures in cerebrospinal fluid (CSF). Association between Aβ and diagnosis (baseline and prospective) was assessed. A number
 of health conditions were associated with altered concentrations of plasma Aβ. The effect of age differed according to AD
 stage. Plasma Aβ1-42 showed mild correlation with other biomarkers o...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5089700</comments>
            <pubDate>Fri, 29 Jul 2011 16:07:26 +0100</pubDate>
            <guid isPermaLink="false">5089700</guid>        </item>
        <item>
            <title>Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice</title>
            <link>http://www.medworm.com/index.php?rid=5064906&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fuv7001715r217213%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Fragile X-associated tremor/ataxia syndrome (FXTAS) is an adult-onset neurodegenerative disorder generally presenting with
 intention tremor and gait ataxia, but with a growing list of co-morbid medical conditions including hypothyroidism, hypertension,
 peripheral neuropathy, and cognitive decline. The pathological hallmark of FXTAS is the presence of intranuclear inclusions
 in both neurons and astroglia. However, it is unknown to what extent such inclusions are present outside the central nervous
 system (CNS). To address this issue, we surveyed non-CNS organs in ten human cases with FXTAS and in a CGG repeat knock-in
 (CGG KI) mouse model known to possess neuronal and astroglial inclusions. We find inclusions in multiple tissues from FXTAS
 cases and CGG KI mice, in...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064906</comments>
            <pubDate>Fri, 22 Jul 2011 17:06:17 +0100</pubDate>
            <guid isPermaLink="false">5064906</guid>        </item>
        <item>
            <title>Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia</title>
            <link>http://www.medworm.com/index.php?rid=5064907&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F38543407608g506l%2F</link>
            <description>In conclusion, post-ischemic neurogenesis in ephrin-B3−/− mice is strongly enhanced, but fails to contribute to functional recovery because of caspase-3-mediated aggravation of ischemic
 injury in these animals. Our results suggest that ephrin-B3 might be an interesting target for overcoming some of the limitations
 of further cell-based therapies in stroke.
 
 
	Content Type Journal ArticlePages 1-14DOI 10.1007/s00401-011-0856-5Authors
		Thorsten R. Doeppner, Department of Neurology, University of Duisburg-Essen Medical School, Hufelandstr. 55, 45122 Essen, GermanyEva Bretschneider, Department of Neurology, University of Goettingen Medical School, 37075 Goettingen, GermanyMaria Doehring, Department of Neurology, University of Goettingen Medical School, 37075 Goettingen, GermanyInmacul...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064907</comments>
            <pubDate>Thu, 21 Jul 2011 18:04:23 +0100</pubDate>
            <guid isPermaLink="false">5064907</guid>        </item>
        <item>
            <title>Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies</title>
            <link>http://www.medworm.com/index.php?rid=5064909&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3885645723430366%2F</link>
            <description>We describe the clinicopathological and biochemical
 features of two cases with GOIs: one with clinical symptoms suggestive of MND and the other with FTD. Histological changes
 in our two cases were consistent with their clinical symptoms; the MND case had severe neurodegeneration in the primary motor
 cortex and corticospinal tract, whereas the FTD case had severe involvement of the frontotemporal cortices and associated
 white matter. Immunohistochemistry in both cases revealed significant 4-repeat (4R) tau pathology primarily in the form of
 GOIs, but also in astrocytes and neurons. Astrocytic tau pathology was morphologically similar to that seen in PSP, but in
 contrast was consistently negative for Gallyas silver staining. Tau-specific western blotting revealed 68, 64 and 35&amp;nbsp;kDa...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064909</comments>
            <pubDate>Wed, 20 Jul 2011 12:08:37 +0100</pubDate>
            <guid isPermaLink="false">5064909</guid>        </item>
        <item>
            <title>Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression</title>
            <link>http://www.medworm.com/index.php?rid=5064908&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F316411j80546857n%2F</link>
            <description>We examined
 in-vivo expression of MIF in 166 gliomas and 23 normal control brains by immunohistochemistry. MIF immunoreactivity was enhanced
 in neoplastic astrocytes in WHO grade II glioma and increased significantly in higher tumour grades (III–IV). MIF expression
 was further assessed in 12 glioma cell lines in vitro. Quantitative RT-PCR showed that MIF mRNA expression was elevated up
 to 800-fold in malignant glioma cells compared with normal brain. This translated into high protein levels as assessed by
 immunoblotting of total cell lysates and by ELISA-based measurement of secreted MIF. Wild-type p53-retaining glioma cell lines
 expressed higher levels of MIF, which may be connected with the previously described role of MIF as a negative regulator of
 wild-type p53 signalling in t...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5064908</comments>
            <pubDate>Wed, 20 Jul 2011 12:08:37 +0100</pubDate>
            <guid isPermaLink="false">5064908</guid>        </item>
        <item>
            <title>High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas</title>
            <link>http://www.medworm.com/index.php?rid=5041734&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg76w7750660pj738%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0855-6Authors
		Jason T. Huse, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USAKhedoudja Nafa, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USANeerav Shukla, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USAEdward R. Kastenhuber, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USAEhud Lavi, Department of Pathology, New York Presbyterian Hospital, New York, NY, USACyrus V. Hedvat, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USAMarc Ladanyi, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USAMarc K. ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5041734</comments>
            <pubDate>Thu, 14 Jul 2011 06:01:45 +0100</pubDate>
            <guid isPermaLink="false">5041734</guid>        </item>
        <item>
            <title>Central nervous system pathology in fatal swine-origin influenza A H1N1 virus infection in patients with and without neurological symptoms: an autopsy study of 15 cases</title>
            <link>http://www.medworm.com/index.php?rid=5022567&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F267148j2827u684q%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0854-7Authors
		Abir Mukherjee, Department of Pathology and Laboratory Medicine, The Methodist Hospital, 6565 Fannin, M227, Houston, TX 77030, USAJo Elle G. Peterson, Department of Pathology and Laboratory Medicine, The Methodist Hospital, 6565 Fannin, M227, Houston, TX 77030, USAGlenn Sandberg, Harris County Institute of Forensic Science, Houston, TX 77054, USAHidehiro Takei, Department of Pathology and Laboratory Medicine, The Methodist Hospital, 6565 Fannin, M227, Houston, TX 77030, USAAdekunle Adesina, Department of Pathology, Texas Children’s Hospital, Houston, TX 77030, USAJ. C. Goodman, Departments of Pathology and Neurology, Baylor College of Medicine, Houston, TX 77030, USASuzanne Powell, Department of Pathology and L...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5022567</comments>
            <pubDate>Sat, 09 Jul 2011 06:18:15 +0100</pubDate>
            <guid isPermaLink="false">5022567</guid>        </item>
        <item>
            <title>Neuropathology underlying clinical variability in patients with synucleinopathies</title>
            <link>http://www.medworm.com/index.php?rid=4994561&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3n14777n2188ql67%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Abnormal aggregates of the synaptic protein, α-synuclein, are the dominant pathology in syndromes known as the synucleinopathies.
 The cellular aggregation of the protein occurs in three distinct types of inclusions in three main clinical syndromes. α-Synuclein
 deposits in neuronal Lewy bodies and Lewy neurites in idiopathic Parkinson’s disease (PD) and dementia with Lewy bodies (DLB),
 as well as incidentally in a number of other conditions. In contrast, α-synuclein deposits largely in oligodendroglial cytoplasmic
 inclusions in multiple system atrophy (MSA). Lastly, α-synuclein also deposits in large axonal spheroids in a number of rarer
 neuroaxonal dystrophies. Disorders are usually defined by their most dominant pathology, but for the synucleinopathies, clin...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4994561</comments>
            <pubDate>Thu, 30 Jun 2011 17:49:09 +0100</pubDate>
            <guid isPermaLink="false">4994561</guid>        </item>
        <item>
            <title>Clinico-pathological correlations in neurodegeneration</title>
            <link>http://www.medworm.com/index.php?rid=4987505&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4174527678422j44%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00401-011-0853-8Authors
		Kurt A. Jellinger, Institute of Clinical Neurobiology, Kenyongasse 18, 1070 Vienna, AustriaGabor G. Kovacs, Institute of Neurology, Medical University of Vienna, Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4987505</comments>
            <pubDate>Tue, 28 Jun 2011 15:49:53 +0100</pubDate>
            <guid isPermaLink="false">4987505</guid>        </item>
        <item>
            <title>Heterogeneity in age-related white matter changes</title>
            <link>http://www.medworm.com/index.php?rid=4971583&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwm075284x7033027%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;White matter changes occur endemically in routine magnetic resonance imaging (MRI) scans of elderly persons. MRI appearance
 and histopathological correlates of white matter changes are heterogeneous. Smooth periventricular hyperintensities, including
 caps around the ventricular horns, periventricular lining and halos are likely to be of non-vascular origin. They relate to
 a disruption of the ependymal lining with subependymal widening of the extracellular space and have to be differentiated from
 subcortical and deep white matter abnormalities. For the latter a distinction needs to be made between punctate, early confluent
 and confluent types. Although punctate white matter lesions often represent widened perivascular spaces without substantial
 ischemic tissue dama...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971583</comments>
            <pubDate>Fri, 24 Jun 2011 16:03:09 +0100</pubDate>
            <guid isPermaLink="false">4971583</guid>        </item>
        <item>
            <title>Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS</title>
            <link>http://www.medworm.com/index.php?rid=4971584&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd82v40166449t3w4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;TDP-43 has been implicated in the pathogenesis of amyotrophic lateral sclerosis and other neurodegenerative diseases. Here
 we demonstrate, using neuronal and spinal cord organotypic culture models, that chronic excitotoxicity, oxidative stress,
 proteasome dysfunction and endoplasmic reticulum stress mechanistically induce mislocalization, phosphorylation and aggregation
 of TDP-43. This is compatible with a lack of function of this protein in the nucleus, specially in motor neurons. The relationship
 between cell stress and pathological changes of TDP-43 also includes a dysfunction in the survival pathway mediated by mitogen-activated
 protein kinase/extracellular signal-regulated kinases (ERK1/2). Thus, under stress conditions, neurons and other spinal cord
 cells sh...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971584</comments>
            <pubDate>Fri, 24 Jun 2011 16:03:06 +0100</pubDate>
            <guid isPermaLink="false">4971584</guid>        </item>
        <item>
            <title>Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice</title>
            <link>http://www.medworm.com/index.php?rid=4971585&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F56t654063t175106%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cerebrovascular lesions related to congophilic amyloid angiopathy (CAA) often accompany deposition of β-amyloid (Aβ) in Alzheimer’s
 disease (AD), leading to disturbed cerebral blood flow and cognitive dysfunction, posing the question how cerebrovascular
 pathology contributes to the pathology of AD. To address this question, we characterised the morphology, biochemistry and
 functionality of brain blood vessels in transgenic arctic β-amyloid (arcAβ) mice expressing human amyloid precursor protein
 (APP) with both the familial AD-causing Swedish and Arctic mutations; these mice are characterised by strong CAA pathology.
 Mice were analysed at early, mid and late-stage pathology. Expression of the glucose transporter GLUT1 at the blood–brain
 barrier (BBB) was si...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971585</comments>
            <pubDate>Tue, 21 Jun 2011 18:00:51 +0100</pubDate>
            <guid isPermaLink="false">4971585</guid>        </item>
        <item>
            <title>Cholinergic imbalance in the multiple sclerosis hippocampus</title>
            <link>http://www.medworm.com/index.php?rid=4971586&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw46172xvhwx07470%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hippocampal pathology was shown to be extensive in multiple sclerosis (MS) and is associated with memory impairment. In this
 post-mortem study, we investigated hippocampal tissue from MS and Alzheimer’s disease (AD) patients and compared these to
 non-neurological controls. By means of biochemical assessment, (immuno)histochemistry and western blot analyses, we detected
 substantial alterations in the cholinergic neurotransmitter system in the MS hippocampus, which were different from those
 in AD hippocampus. In MS hippocampus, activity and protein expression of choline acetyltransferase (ChAT), the acetylcholine
 synthesizing enzyme, was decreased, while the activity and protein expression of acetylcholinesterase (AChE), the acetylcholine
 degrading enzyme, was fou...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4971586</comments>
            <pubDate>Tue, 21 Jun 2011 16:43:20 +0100</pubDate>
            <guid isPermaLink="false">4971586</guid>        </item>
        <item>
            <title>Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct</title>
            <link>http://www.medworm.com/index.php?rid=4947385&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv552l3w661814855%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Recent integrative genomic approaches have defined molecular subgroups of medulloblastoma that are genetically and clinically
 distinct. Sonic hedgehog (Shh) medulloblastomas account for one-third of all cases and comprise the majority of infant and
 adult medulloblastomas. To discern molecular heterogeneity among Shh-medulloblastomas, we analyzed transcriptional profiles
 from four independent Shh-medulloblastoma expression datasets (n&amp;nbsp;=&amp;nbsp;66). Unsupervised clustering analyses demonstrated a clear distinction between infant and adult Shh-medulloblastomas, which
 was reliably replicated across datasets. Comparison of transcriptomes from infant and adult Shh-medulloblastomas revealed
 deregulation of multiple gene families, including genes implicated in cellular ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947385</comments>
            <pubDate>Fri, 17 Jun 2011 10:51:18 +0100</pubDate>
            <guid isPermaLink="false">4947385</guid>        </item>
        <item>
            <title>The spinal muscular atrophy mouse model, SMAΔ7, displays altered axonal transport without global neurofilament alterations</title>
            <link>http://www.medworm.com/index.php?rid=4947386&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc43t2197l0v4652g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Spinal muscular atrophy (SMA) is a neurodegenerative disease resulting from decreased levels of survival motor neuron 1 (SMN1)
 protein. Reduced SMN1 levels are linked to pathology at neuromuscular junctions (NMJs), which includes decreased vesicle density
 and organization, decreased quantal release, increased endplate potential duration, and neurofilament (NF) accumulations.
 This work presents a first study towards defining molecular alterations that may lead to the development of NMJ pathology
 in SMA. Fast, anterograde transport of synaptic vesicle 2 (SV2-c) and synaptotagmin (Syt1) proteins was reduced 2&amp;nbsp;days prior
 to the observed decrease in synaptic vesicle density. Moreover, reduced accumulation of SV2-c or Syt1 was not due to reduced
 protein expression ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4947386</comments>
            <pubDate>Fri, 17 Jun 2011 10:51:17 +0100</pubDate>
            <guid isPermaLink="false">4947386</guid>        </item>
        <item>
            <title>Brain microvascular pericytes in health and disease</title>
            <link>http://www.medworm.com/index.php?rid=4924625&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq2878066430mp710%2F</link>
            <description>In conclusion, although the evidence is just emerging and
 mostly preliminary, disclosing pericytes’ role in the pathophysiology of CNS diseases may yield exciting developments and
 novel treatments.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s00401-011-0847-6Authors
		Turgay Dalkara, Department of Neurology, Faculty of Medicine and, Institute of Neurological Sciences and Psychiatry, Hacettepe University, Sihhiye, Ankara, TurkeyYasemin Gursoy-Ozdemir, Department of Neurology, Faculty of Medicine and, Institute of Neurological Sciences and Psychiatry, Hacettepe University, Sihhiye, Ankara, TurkeyMuge Yemisci, Department of Neurology, Faculty of Medicine and, Institute of Neurological Sciences and Psychiatry, Hacettepe University, Sihhiye, Ankara, Turkey
	

	
		Journal Acta Neur...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4924625</comments>
            <pubDate>Wed, 08 Jun 2011 15:46:32 +0100</pubDate>
            <guid isPermaLink="false">4924625</guid>        </item>
        <item>
            <title>Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation</title>
            <link>http://www.medworm.com/index.php?rid=4915468&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa1842t155278161j%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We investigated a family manifesting amyotrophic lateral sclerosis (ALS) with a heterozygous E478G mutation in the optineurin (OPTN) gene. Clinically, slow deterioration of motor function, mood and personality changes, temporal lobe atrophy on neuroimaging,
 and bizarre finger deformity were noted. Neuropathologically, TAR DNA-binding protein 43 (TDP-43)-positive neuronal intracytoplasmic
 inclusions were observed in the spinal and medullary motor neurons. In these cells, the immunoreactivity of nuclear TDP-43
 was reduced. Consecutive sections revealed that the inclusions were also reactive with anti-ubiquitin and anti-p62 antibodies,
 but noticeably negative for OPTN. In addition, TDP-43/p62-positive glial cytoplasmic inclusions (GCIs) were scattered throughout
 the s...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915468</comments>
            <pubDate>Sun, 05 Jun 2011 05:46:46 +0100</pubDate>
            <guid isPermaLink="false">4915468</guid>        </item>
        <item>
            <title>A harmonized classification system for FTLD-TDP pathology</title>
            <link>http://www.medworm.com/index.php?rid=4915469&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1h9864644565qh2%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0845-8Authors
		Ian R. A. Mackenzie, Department of Pathology, University of British Columbia and Vancouver General Hospital, 855 West 12th Avenue, Vancouver, British Columbia V5Z 1M9, CanadaManuela Neumann, Institute of Neuropathology, University Hospital Zurich, Zurich, SwitzerlandAtik Baborie, Department of Neuropathology, Walton Center for Neurology and Neurosurgery, Liverpool, UKDeepak M. Sampathu, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Pennsylvania, PA, USADaniel Du Plessis, Department of Pathology, Hope Hospital, Salford, UKEvelyn Jaros, Department of Neuropathology, Newcastle General Hospital, Newcastle-Upon-Tyne, UKRobert H. Perry, Department of Neuropathology, New...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4915469</comments>
            <pubDate>Sun, 05 Jun 2011 05:46:44 +0100</pubDate>
            <guid isPermaLink="false">4915469</guid>        </item>
        <item>
            <title>The cerebellar component of Friedreich’s ataxia</title>
            <link>http://www.medworm.com/index.php?rid=4896747&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxx54g7322l22j251%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lack of frataxin in Friedreich’s ataxia (FRDA) causes a complex neurological and pathological phenotype. Progressive atrophy
 of the dentate nucleus (DN) is a major intrinsic central nervous system lesion. Antibodies to neuron-specific enolase (NSE),
 calbindin, glutamic acid decarboxylase (GAD), and vesicular glutamate transporters 1 and 2 (VGluT1, VGluT2) allowed insight
 into the disturbed synaptic circuitry of the DN. The available case material included autopsy specimens of 24 patients with
 genetically defined FRDA and 14 normal controls. In FRDA, the cerebellar cortex revealed intact Purkinje cell somata and dendrites
 as assessed by calbindin immunoreactivity. The DN, however, displayed severe loss of large NSE-reactive neurons. Small neurons
 remained intact....</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896747</comments>
            <pubDate>Fri, 03 Jun 2011 05:55:52 +0100</pubDate>
            <guid isPermaLink="false">4896747</guid>        </item>
        <item>
            <title>Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody</title>
            <link>http://www.medworm.com/index.php?rid=4896748&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe442228q367373ln%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Activating mutations of the serine threonine kinase v-RAF murine sarcoma viral oncogene homolog B1 (BRAF) are frequent in
 benign and malignant human tumors and are emerging as an important biomarker. Over 95% of BRAF mutations are of the V600E
 type and specific small molecular inhibitors are currently under pre-clinical or clinical investigation. BRAF mutation status is determined by DNA-based methods, most commonly by sequencing. Here we describe the development of a monoclonal
 BRAF V600E mutation-specific antibody that can differentiate BRAF V600E and wild type protein in routinely processed formalin-fixed
 and paraffin-embedded tissue. A total of 47 intracerebral melanoma metastases and 21 primary papillary thyroid carcinomas
 were evaluated by direct sequencing o...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896748</comments>
            <pubDate>Fri, 03 Jun 2011 05:55:51 +0100</pubDate>
            <guid isPermaLink="false">4896748</guid>        </item>
        <item>
            <title>Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4896749&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl488322054456465%2F</link>
            <description>We examined the distribution of PSD-95 in transgenic mice of amyloidopathy (5XFAD) and tauopathy (JNPL3) as well as in AD
 brains using double-labeling immunofluorescence and confocal microscopy. In wild type control mice, PSD-95 primarily labeled
 neuropil with distinct distribution in hippocampal apical dendrites. In 3-month-old 5XFAD mice, PSD-95 distribution was similar
 to that of wild type mice despite significant Aβ deposition. However, in 6-month-old 5XFAD mice, PSD-95 immunoreactivity in
 apical dendrites markedly decreased and prominent immunoreactivity was noted in neuronal soma in CA1 neurons. Similarly, PSD-95
 immunoreactivity disappeared from apical dendrites and accumulated in neuronal soma in 14-month-old, but not in 3-month-old,
 JNPL3 mice. In AD brains, PSD-95 accumula...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896749</comments>
            <pubDate>Wed, 01 Jun 2011 06:01:51 +0100</pubDate>
            <guid isPermaLink="false">4896749</guid>        </item>
        <item>
            <title>The neuropathological basis of clinical progression in multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4896750&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu0521l8031711v52%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple sclerosis is the major inflammatory condition affecting the central nervous system (CNS) and is characterised by
 disseminated focal immune-mediated demyelination. Demyelination is accompanied by variable axonal damage and loss and reactive
 gliosis. It is this pathology that is thought to be responsible for the clinical relapses that often respond well to immunomodulatory
 therapy. However, the later secondary progressive stage of MS remains largely refractory to treatment and it is widely suggested
 that accumulating axon loss is responsible for clinical progression. Although initially thought to be a white matter (WM)
 disease, it is increasingly apparent that extensive pathology is also seen in the grey matter (GM) throughout the CNS. GM
 pathology is chara...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896750</comments>
            <pubDate>Fri, 27 May 2011 18:13:45 +0100</pubDate>
            <guid isPermaLink="false">4896750</guid>        </item>
        <item>
            <title>Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment</title>
            <link>http://www.medworm.com/index.php?rid=4896751&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu553960215345r5g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with variable involvement of other systems. A pathogenetic
 role of immune-mediated mechanisms has been suggested. We retrospectively analyzed sural nerve pathology and the clinical
 course in 18 patients with ALS. These patients had undergone sural nerve biopsy because of clinical or neurophysiological
 signs indicating sensory involvement (ALS+). Eleven of the 18 ALS+ patients had inflammatory cell infiltrates (ALSvasc) resembling infiltrates seen in patients with vasculitic neuropathy. Data were compared with the 7 patients without vasculitic
 infiltrates (ALSnonvasc) and with those of 16 patients with isolated peripheral nerve vasculitis (NPvasc). Biopsy specimens were processed with standard histol...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896751</comments>
            <pubDate>Fri, 27 May 2011 18:13:44 +0100</pubDate>
            <guid isPermaLink="false">4896751</guid>        </item>
        <item>
            <title>Neuropathological background of phenotypical variability in frontotemporal dementia</title>
            <link>http://www.medworm.com/index.php?rid=4896752&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv50803240426756l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Frontotemporal lobar degeneration (FTLD) is the umbrella term encompassing a heterogeneous group of pathological disorders.
 With recent discoveries, the FTLDs have been show to classify nicely into three main groups based on the major protein deposited
 in the brain: FTLD-tau, FTLD-TDP and FTLD-FUS. These pathological groups, and their specific pathologies, underlie a number
 of well-defined clinical syndromes, including three frontotemporal dementia (FTD) variants [behavioral variant frontotemporal
 dementia (bvFTD), progressive non-fluent aphasia, and semantic dementia (SD)], progressive supranuclear palsy syndrome (PSPS)
 and corticobasal syndrome (CBS). Understanding the neuropathological background of the phenotypic variability in FTD, PSPS
 and CBS requires large...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896752</comments>
            <pubDate>Wed, 25 May 2011 15:56:53 +0100</pubDate>
            <guid isPermaLink="false">4896752</guid>        </item>
        <item>
            <title>Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation</title>
            <link>http://www.medworm.com/index.php?rid=4896753&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk328t20260588221%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Mutations in the gene encoding the fused in sarcoma (FUS) protein are responsible for ~3% of familial amyotrophic lateral
 sclerosis (ALS) and &amp;lt;1% of sporadic ALS (ALS-FUS). Descriptions of the associated neuropathology are few and largely restricted to individual case reports. To better define
 the neuropathology associated with FUS mutations, we have undertaken a detailed comparative analysis of six cases of ALS-FUS that include sporadic and familial cases, with both juvenile and adult onset, and with four different FUS mutations. We found significant pathological heterogeneity among our cases, with two distinct patterns that correlated with
 the disease severity and the specific mutation. Frequent basophilic inclusions and round FUS-immunoreactive (FUS-ir) neurona...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4896753</comments>
            <pubDate>Sat, 21 May 2011 23:21:48 +0100</pubDate>
            <guid isPermaLink="false">4896753</guid>        </item>
        <item>
            <title>Peroxisomal alterations in Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4856311&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg7247x8002q00685%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In Alzheimer’s disease (AD), lipid alterations are present early during disease progression. As some of these alterations
 point towards a peroxisomal dysfunction, we investigated peroxisomes in human postmortem brains obtained from the cohort-based,
 longitudinal Vienna-Transdanube Aging (VITA) study. Based on the neuropathological Braak staging for AD on one hemisphere,
 the patients were grouped into three cohorts of increasing severity (stages I–II, III–IV, and V–VI, respectively). Lipid analyses
 of cortical regions from the other hemisphere revealed accumulation of C22:0 and very long-chain fatty acids (VLCFA, C24:0
 and C26:0), all substrates for peroxisomal β-oxidation, in cases with stages V–VI pathology compared with those modestly affected
 (stages...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4856311</comments>
            <pubDate>Thu, 19 May 2011 05:46:52 +0100</pubDate>
            <guid isPermaLink="false">4856311</guid>        </item>
        <item>
            <title>Spindle cell oncocytoma of the pituitary gland with follicle-like component: organotypic differentiation to support its origin from folliculo-stellate cells</title>
            <link>http://www.medworm.com/index.php?rid=4856312&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy033025g18232k37%2F</link>
            <description>We describe a unique example of SCO wherein a conventional fascicular texture
 was seen coexisting with and organically merging into follicle-like arrangements. The sellar tumor of 2.7&amp;nbsp;×&amp;nbsp;2.6&amp;nbsp;×&amp;nbsp;2.5&amp;nbsp;cm was
 transphenoidally resected from a 55-year old female. Preoperative magnetic resonance imaging indicated an isointense, contrast
 enhancing mass with suprasellar extension. Histology showed multiple rudimentary to well-formed, follicle-like cavities on
 a classical spindle cell background; while all the participating cells exhibited an SCO immunophenotype, including positivity
 for S100 protein, vimentin, EMA, Bcl-2, and TTF-1, as well as staining with the antimitochondrial antibody 113-1. Conversely
 no expression of GFAP, follicular-epithelial cytokeratin, carci...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4856312</comments>
            <pubDate>Wed, 18 May 2011 06:18:00 +0100</pubDate>
            <guid isPermaLink="false">4856312</guid>        </item>
        <item>
            <title>SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation</title>
            <link>http://www.medworm.com/index.php?rid=4856313&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp3611622n73lx403%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The suppressor of cytokine signaling 3 (SOCS3) gene is one of eight structurally related genes of the SOCS family and has been suggested to function as a tumor suppressor
 by inhibition of the JAK/STAT signaling pathway. We investigated 60 human gliomas of different histological types for SOCS3 alterations and found frequent SOCS3 promoter hypermethylation and transcriptional downregulation. However, SOCS3 promoter hypermethylation was virtually absent in primary glioblastomas, which are characterized by frequent epidermal growth
 factor receptor (EGFR) amplification and overexpression. Assessment of the relationship between SOCS3 and EGFR aberrations revealed that SOCS3 promoter hypermethylation was inversely related to both the EGFR gene dosage as well as the EGFR pro...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4856313</comments>
            <pubDate>Wed, 18 May 2011 06:17:59 +0100</pubDate>
            <guid isPermaLink="false">4856313</guid>        </item>
        <item>
            <title>Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts</title>
            <link>http://www.medworm.com/index.php?rid=4833410&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe68h44607q804314%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA) are adult onset neurodegenerative
 disorders characterised by prominent intracellular α-synuclein aggregates (α-synucleinopathies). The glial contribution to
 neurodegeneration in α-synucleinopathies was largely underestimated until recently. However, brains of PD and DLB patients
 exhibit not only neuronal inclusions such as Lewy bodies or Lewy neurites but also glial α-synuclein aggregates. Accumulating
 experimental evidence in PD models suggests that astrogliosis and microgliosis act as important mediators of neurodegeneration
 playing a pivotal role in both disease initiation and progression. In MSA, oligodendrocytes are intriguingly affected by aberrant
 cytoplasmic a...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4833410</comments>
            <pubDate>Thu, 12 May 2011 19:26:26 +0100</pubDate>
            <guid isPermaLink="false">4833410</guid>        </item>
        <item>
            <title>Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders</title>
            <link>http://www.medworm.com/index.php?rid=4807654&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe5645018442hj723%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Olfactory dysfunction is a frequent and early feature of patients with neurodegenerative disorders such as Alzheimer’s disease
 (AD) and Parkinson’s disease (PD) and is very uncommon in patients with frontotemporal dementia (FTD). Mechanisms underlying
 this clinical manifestation are poorly understood but the premature deposition of protein aggregates in the olfactory bulb
 (OB) of these patients might impair its synaptic organization, thus accounting for the smell deficits. Tau, β-amyloid and
 alpha-synuclein deposits were studied in 41 human OBs with histological diagnosis of AD (n&amp;nbsp;=&amp;nbsp;24), PD (n&amp;nbsp;=&amp;nbsp;6), FTD (n&amp;nbsp;=&amp;nbsp;11) and compared with the OB of 15 control subjects. Tau pathology was present in the OB of all patients, irrespective
 of th...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4807654</comments>
            <pubDate>Sat, 07 May 2011 15:45:20 +0100</pubDate>
            <guid isPermaLink="false">4807654</guid>        </item>
        <item>
            <title>Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death</title>
            <link>http://www.medworm.com/index.php?rid=4791232&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe2w286484498651g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Dopaminergic (DA) neuron degeneration is a feature of brain aging but is markedly increased in patients with Parkinson’s disease
 (PD). Recent data indicate elevated metabolic stress as a possible explanation for DA neuron vulnerability. Using laser capture
 microdissection, we isolated DA neurons from the substantia nigra pars compacta of PD patients, age-matched and young controls
 to determine transcriptional changes by expression profiling and pathway analysis. We verified our findings by comparison
 to a published dataset. Parallel processing of isolated neurons and bulk tissue allowed the discrimination of neuronal and
 glial transcription signals. Our data show that genes known to be involved in neural plasticity, axon and synaptic function,
 as well as cell fa...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4791232</comments>
            <pubDate>Tue, 03 May 2011 19:47:29 +0100</pubDate>
            <guid isPermaLink="false">4791232</guid>        </item>
        <item>
            <title>Intravascular mucinosis: a rare cause of cerebral infarction</title>
            <link>http://www.medworm.com/index.php?rid=4791234&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm63546q51752367m%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00401-011-0829-8Authors
		Marie Christine Bernardo, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USAJonathan Graff Radford, Department of Neurology, Mayo Clinic, Rochester, MN, USAJoshua Menke, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USAChristopher Hallemeier, Department of Neurology, Mayo Clinic, Rochester, MN, USAChristopher J. Boes, Department of Neurology, Mayo Clinic, Rochester, MN, USAMark Lewis, Department of Neurology, Mayo Clinic, Rochester, MN, USABernd Scheithauer, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USACaterina Giannini, Department of Labo...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4791234</comments>
            <pubDate>Tue, 03 May 2011 19:47:28 +0100</pubDate>
            <guid isPermaLink="false">4791234</guid>        </item>
        <item>
            <title>Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4784090&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk32202p145864503%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Amyloid imaging has identified cognitively normal older people with plaques as a group possibly at increased risk for developing
 Alzheimer’s disease-related dementia. It is important to begin to thoroughly characterize this group so that preventative
 therapies might be tested. Existing cholinotropic agents are a logical choice for preventative therapy as experimental evidence
 suggests that they are anti-amyloidogenic and clinical trials have shown that they delay progression of mild cognitive impairment
 to dementia. A detailed understanding of the status of the cortical cholinergic system in preclinical AD is still lacking,
 however. For more than 30&amp;nbsp;years, depletion of the cortical cholinergic system has been known to be one of the characteristic
 features o...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4784090</comments>
            <pubDate>Sat, 30 Apr 2011 23:41:13 +0100</pubDate>
            <guid isPermaLink="false">4784090</guid>        </item>
        <item>
            <title>In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology</title>
            <link>http://www.medworm.com/index.php?rid=4769019&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F62132k156j7359h4%2F</link>
            <description>Content Type Journal ArticlePages 565-568DOI 10.1007/s00401-011-0827-xAuthors
		Hans Lassmann, Center for Brain Research, Medical University of Vienna, Vienna, AustriaChristian Bancher, Department of Neurology, Landesklinikum Waldviertel Horn-Allentsteig, Horn, AustriaJohannes Attems, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UKWerner Paulus, Institute of Neuropathology, University Hospital Münster, Domagkstr. 19, 48129 Münster, Germany
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322
	
		Journal Volume Volume 121
	
		Journal Issue Volume 121, Number 5 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4769019</comments>
            <pubDate>Tue, 26 Apr 2011 15:46:41 +0100</pubDate>
            <guid isPermaLink="false">4769019</guid>        </item>
        <item>
            <title>Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies</title>
            <link>http://www.medworm.com/index.php?rid=4769020&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87261713m7u0p332%2F</link>
            <description>In conclusion, it may be most fruitful to focus attention on specific pathways involved
 in AD rather than attributing it to an inevitable consequence of aging.
 
 
	Content Type Journal ArticlePages 571-587DOI 10.1007/s00401-011-0826-yAuthors
		Peter T. Nelson, Department of Pathology, University of Kentucky, Rm 311, Sanders-Brown Building, 800 S. Limestone, Lexington, KY 40536-0230, USAElizabeth Head, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536-0230, USAFrederick A. Schmitt, Division of Neuropathology, Department of Neurology, University of Kentucky, Lexington, KY 40536-0230, USAPaulina R. Davis, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536-0230, USAJanna H. Neltner, Department of Pathology, University of Kentucky, Rm 311, Sand...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4769020</comments>
            <pubDate>Sun, 24 Apr 2011 05:32:22 +0100</pubDate>
            <guid isPermaLink="false">4769020</guid>        </item>
        <item>
            <title>Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?</title>
            <link>http://www.medworm.com/index.php?rid=4769021&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff077351147171t21%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is increasing interest in the early phase of Alzheimer’s disease before severe neuronal dysfunction occurs, but it is
 still not known when or where in the central nervous system the underlying pathological process begins. In this review, we
 discuss the idea of possible disease progression from the locus coeruleus to the transentorhinal region of the cerebral cortex
 via neuron-to-neuron transmission and transsynaptic transport of tau protein aggregates, and we speculate that such a mechanism
 together with the very long prodromal period that characterizes Alzheimer’s disease may be indicative of a prion-like pathogenesis
 for this tauopathy. The fact that AT8-immunoreactive abnormal tau aggregates (pretangles) develop within proximal axons of
 noradrenergic ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4769021</comments>
            <pubDate>Sun, 24 Apr 2011 05:32:20 +0100</pubDate>
            <guid isPermaLink="false">4769021</guid>        </item>
        <item>
            <title>Pathogenic T cell responses against aquaporin 4</title>
            <link>http://www.medworm.com/index.php?rid=4688084&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj275135731710674%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Inflammatory lesions in the central nervous system of patients with neuromyelitis optica are characterized by infiltration
 of T cells and deposition of aquaporin-4-specific antibodies and complement on astrocytes at the glia limitans. Although the
 contribution of aquaporin-4-specific autoantibodies to the disease process has been recently elucidated, a potential role
 of aquaporin-4-specific T cells in lesion formation is unresolved. To address this issue, we raised aquaporin-4-specific T
 cell lines in Lewis rats and characterized their pathogenic potential in the presence and absence of aquaporin-4-specific
 autoantibodies of neuromyelitis optica patients. We show that aquaporin-4-specific T cells induce brain inflammation with
 particular targeting of the astrocyti...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688084</comments>
            <pubDate>Wed, 06 Apr 2011 06:44:39 +0100</pubDate>
            <guid isPermaLink="false">4688084</guid>        </item>
        <item>
            <title>TSEN54 mutation in a child with pontocerebellar hypoplasia type 1</title>
            <link>http://www.medworm.com/index.php?rid=4688085&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8mgm37488235x43k%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0823-1Authors
		Alessandro Simonati, Department of Neurological, Psychological, Morphological and Motor Sciences, Divisions of Neurology (Child Neurology) and Neuropathology, University of Verona Medical School, Policlinico G.B. Rossi, P.le LA Scuro 10, 37134 Verona, ItalyDenise Cassandrini, Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, ItalyDiana Bazan, Department of Neurological, Psychological, Morphological and Motor Sciences, Divisions of Neurology (Child Neurology) and Neuropathology, University of Verona Medical School, Policlinico G.B. Rossi, P.le LA Scuro 10, 37134 Verona, ItalyFilippo Maria Santorelli, Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa, Italy
	

	
		Journal Acta NeuropathologicaOnline IS...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4688085</comments>
            <pubDate>Tue, 05 Apr 2011 16:58:20 +0100</pubDate>
            <guid isPermaLink="false">4688085</guid>        </item>
        <item>
            <title>Fifty years of Acta Neuropathologica: past, present, and future</title>
            <link>http://www.medworm.com/index.php?rid=4678416&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F917q600376046514%2F</link>
            <description>Fifty years of Acta Neuropathologica: past, present, and future
	Content Type Journal ArticlePages 1-2DOI 10.1007/s00401-011-0822-2Authors
		Werner Paulus, Institute of Neuropathology, University Hospital Münster, Domagkstr. 19, 48129 Munster, GermanyKurt A. Jellinger, Institute of Clinical Neurobiology, Kenyongasse 18, 1070 Vienna, Austria
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678416</comments>
            <pubDate>Thu, 31 Mar 2011 17:37:53 +0100</pubDate>
            <guid isPermaLink="false">4678416</guid>        </item>
        <item>
            <title>Clinicopathological correlates of behavioral and psychological symptoms of dementia</title>
            <link>http://www.medworm.com/index.php?rid=4678417&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqq487nx55r3n0j76%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Behavioral and psychological symptoms are commonly observed in a majority of demented patients at some time during the course
 of their illness. Many of these psychiatric manifestations, especially those related to mood, may be early expressions of
 dementia and/or mild cognitive impairment. The literature suggests that behavioral and psychological symptoms of dementia
 (BPSD) are an integral part of the disease process. The dissociation, in many cases, between BPSD and the rather linear decline
 in cognitive functions suggests that independent pathophysiological mechanisms give rise to these symptoms. A review of the
 neuroimaging and neuropathology literature indicates that BPSD are the expression of regional rather than diffuse brain pathology.
 Psychotic symptoms in...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4678417</comments>
            <pubDate>Thu, 31 Mar 2011 17:37:52 +0100</pubDate>
            <guid isPermaLink="false">4678417</guid>        </item>
        <item>
            <title>A peculiar constellation of tau pathology defines a subset of dementia in the elderly</title>
            <link>http://www.medworm.com/index.php?rid=4646168&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F51017063h43007v4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Sporadic tauopathies are characterized by differential cellular and topographical predominance of phospho-tau immunoreactivity
 and biochemical distinction of the tau protein. Established entities include progressive supranuclear palsy, corticobasal
 degeneration, Pick’s disease, and argyrophilic grain disease. During a community-based longitudinal study on aging, we detected
 tau pathologies not compatible with these categories. We immunostained for different phospho-tau epitopes, 4R and 3R tau isoforms,
 α-synuclein, amyloid-β, and phospho-TDP-43, analyzed the MAPT and ApoE genes, and performed western blotting for the tau protein. The mean age of patients (4 women, 3 men) was 83.8&amp;nbsp;years. Clinical
 presentations combined dementia with psychiatric symptoms and...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4646168</comments>
            <pubDate>Fri, 25 Mar 2011 05:49:59 +0100</pubDate>
            <guid isPermaLink="false">4646168</guid>        </item>
        <item>
            <title>Trisomy 6p and ring chromosome 11 in a melanotic schwannoma suggest relation to malignant melanoma rather than conventional schwannoma</title>
            <link>http://www.medworm.com/index.php?rid=4628326&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw46k266016032632%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00401-011-0820-4Authors
		Antoine Italiano, Laboratory of Solid Tumors Genetics, Faculty of Medicine, Nice University Hospital, Nice, FranceSophie Michalak, Department of Pathology, Centre Paul Papin, Angers, FrancePatrick Soulié, Department of Medical Oncology, Centre Paul Papin, Angers, FranceAnnie-Claude Peyron, Laboratory of Solid Tumors Genetics, Faculty of Medicine, Nice University Hospital, Nice, FranceFlorence Pedeutour, Laboratory of Solid Tumors Genetics, Faculty of Medicine, Nice University Hospital, Nice, France
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628326</comments>
            <pubDate>Mon, 21 Mar 2011 18:55:57 +0100</pubDate>
            <guid isPermaLink="false">4628326</guid>        </item>
        <item>
            <title>A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy</title>
            <link>http://www.medworm.com/index.php?rid=4628327&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5p00586528765h11%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Axial myopathy is a rare neuromuscular disease that is characterized by paraspinal muscle atrophy and abnormal posture, most
 notably camptocormia (also known as bent spine). The genetic cause of familial axial myopathy is unknown. Described here are
 the clinical features and cause of late-onset predominant axial myopathy and encephalopathy. A 73-year-old woman presented
 with a 10-year history of severe paraspinal muscle atrophy and cerebellar ataxia. Her 84-year-old sister also developed late-onset
 paraspinal muscle atrophy and generalized seizures with encephalopathy. Computed tomography showed severe atrophy and fatty
 degeneration of their paraspinal muscles. Their mother and maternal aunt also developed bent spines. The existence of many
 ragged-red fibers and c...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4628327</comments>
            <pubDate>Mon, 21 Mar 2011 18:55:55 +0100</pubDate>
            <guid isPermaLink="false">4628327</guid>        </item>
        <item>
            <title>The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene</title>
            <link>http://www.medworm.com/index.php?rid=4617836&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq82x38830242864w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Frontotemporal lobar degeneration (FTLD) is clinically, pathologically and genetically heterogeneous. Recent descriptions
 of a pathological sub-type that is ubiquitin positive, TDP-43 negative and immunostains positive for the Fused in Sarcoma
 protein (FUS) raises the question whether it is associated with a distinct clinical phenotype identifiable on clinical grounds,
 and whether mutations in the Fused in Sarcoma gene (FUS) might also be associated with FTLD. Examination of a pathological series of 118 cases of FTLD from two centres, showing
 tau-negative, ubiquitin-positive pathology, revealed FUS pathology in five patients, four classified as atypical FTLD with
 ubiquitin inclusions (aFTLD-U), and one as neuronal intermediate filament inclusion disease (NIFID). Th...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617836</comments>
            <pubDate>Sat, 19 Mar 2011 16:59:49 +0100</pubDate>
            <guid isPermaLink="false">4617836</guid>        </item>
        <item>
            <title>Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma</title>
            <link>http://www.medworm.com/index.php?rid=4617837&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0hrq6203xl6642h6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Activation of the MAPK signaling pathway has been shown to be a unifying molecular feature in pilocytic astrocytoma (PA).
 Genetically, tandem duplications at chromosome 7q34 resulting in KIAA1549–BRAF fusion genes constitute the most common mechanism identified to date. To elucidate alternative mechanisms of aberrant MAPK
 activation in PA, we screened 125 primary tumors for RAF fusion genes and mutations in KRAS, NRAS, HRAS, PTPN11, BRAF and RAF1. Using microarray-based comparative genomic hybridization (aCGH), we identified in three cases an interstitial deletion of
 ~2.5&amp;nbsp;Mb as a novel recurrent mechanism forming BRAF gene fusions with FAM131B, a currently uncharacterized gene on chromosome 7q34. This deletion removes the BRAF N-terminal inhibitory domains, gi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4617837</comments>
            <pubDate>Sat, 19 Mar 2011 16:59:47 +0100</pubDate>
            <guid isPermaLink="false">4617837</guid>        </item>
        <item>
            <title>Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease</title>
            <link>http://www.medworm.com/index.php?rid=4597019&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61142r5h3h57671x%2F</link>
            <description>In this study, we quantify and identify relationships between the levels of the main pathologic form
 of phosphorylated α-synuclein over the course of Parkinson’s disease in regions affected early through to end-stage disease.
 Brain tissue samples from 33 cases at different disease stages and 13 controls were collected through the Australian Network
 of Brain Banks. 500&amp;nbsp;mg of frozen putamen (affected preclinically) and frontal cortex (affected late) was homogenized, fractionated
 and α-synuclein levels evaluated using specific antibodies (syn-1, BD Transduction Laboratories; S129P phospho-α-synuclein,
 Elan Pharmaceuticals) and quantitative western blotting. Statistical analyses assessed the relationship between the different
 forms of α-synuclein, compared levels between group...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4597019</comments>
            <pubDate>Sat, 12 Mar 2011 07:01:27 +0100</pubDate>
            <guid isPermaLink="false">4597019</guid>        </item>
        <item>
            <title>Axonopathy is a compounding factor in the pathogenesis of Krabbe disease</title>
            <link>http://www.medworm.com/index.php?rid=4562541&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6478834640567753%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Loss-of-function of the lysosomal enzyme galactosyl-ceramidase causes the accumulation of the lipid raft-associated sphingolipid
 psychosine, the disruption of postnatal myelination, neurodegeneration and early death in most cases of infantile Krabbe disease.
 This work presents a first study towards understanding the progression of axonal defects in this disease using the Twitcher
 mutant mouse. Axonal swellings were detected in axons within the mutant spinal cord as early as 1&amp;nbsp;week after birth. As the
 disease progressed, more axonopathic profiles were found in other regions of the nervous system, including peripheral nerves
 and various brain areas. Isolated mutant neurons recapitulated axonal and neuronal defects in the absence of mutant myelinating
 glia, sugg...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4562541</comments>
            <pubDate>Fri, 04 Mar 2011 10:49:00 +0100</pubDate>
            <guid isPermaLink="false">4562541</guid>        </item>
        <item>
            <title>Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders</title>
            <link>http://www.medworm.com/index.php?rid=4537335&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fap108424q7125779%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Optineurin (OPTN) is a multifunctional protein involved in vesicular trafficking, signal transduction and gene expression.
 OPTN mutations were described in eight Japanese patients with familial and sporadic amyotrophic lateral sclerosis (FALS, SALS).
 OPTN-positive inclusions co-localising with TDP-43 were described in SALS and in FALS with SOD-1 mutations, potentially linking two pathologically distinct pathways of motor neuron degeneration. We have explored the abundance
 of OPTN inclusions using a range of antibodies in postmortem tissues from 138 cases and controls including sporadic and familial
 ALS, frontotemporal lobar degeneration (FTLD) and a wide range of neurodegenerative proteinopathies. OPTN-positive inclusions
 were uncommon and detected in only 11/32 (3...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4537335</comments>
            <pubDate>Mon, 28 Feb 2011 16:45:30 +0100</pubDate>
            <guid isPermaLink="false">4537335</guid>        </item>
        <item>
            <title>Thanks to referees</title>
            <link>http://www.medworm.com/index.php?rid=4514257&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx2565024384208u7%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0812-4

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4514257</comments>
            <pubDate>Mon, 21 Feb 2011 16:56:43 +0100</pubDate>
            <guid isPermaLink="false">4514257</guid>        </item>
        <item>
            <title>TDP-43 pathology may occur in the BRI2 gene-related dementias</title>
            <link>http://www.medworm.com/index.php?rid=4514258&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe706186g83l1r115%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00401-011-0811-5Authors
		Tammaryn Lashley, Department of Molecular Neuroscience, Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, Queen Square, London, WC1N 3BG UKJanice L. Holton, Department of Molecular Neuroscience, Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, Queen Square, London, WC1N 3BG UKTamas Revesz, Department of Molecular Neuroscience, Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, Queen Square, London, WC1N 3BG UK
	

	
		Journal Acta NeuropathologicaOnline ISSN 1432-0533Print ISSN 0001-6322 (Source: Acta Neuropathologica)</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4514258</comments>
            <pubDate>Mon, 21 Feb 2011 16:56:42 +0100</pubDate>
            <guid isPermaLink="false">4514258</guid>        </item>
        <item>
            <title>Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts</title>
            <link>http://www.medworm.com/index.php?rid=4498917&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff51797p822u7k7xk%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Diffuse astrocytomas (WHO grade II) typically present as slow-growing tumours showing significant cellular differentiation,
 but possessing a tendency towards malignant progression. They account for ~10% of all astrocytic tumours, with a peak incidence
 between 30 and 40&amp;nbsp;years of age. Median survival is reported as around 6–8&amp;nbsp;years. Mutations of TP53 and IDH1 have been described as genetic hallmarks, while copy number alterations are also relatively common. However, there is some
 evidence to suggest that these characteristics may vary with age. Here, we present an integrated clinicopathologic, genomic
 and transcriptomic analysis suggesting that paediatric and adult tumours are associated with distinct genetic signatures.
 For example, no childhood tumour s...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4498917</comments>
            <pubDate>Thu, 17 Feb 2011 08:13:12 +0100</pubDate>
            <guid isPermaLink="false">4498917</guid>        </item>
        <item>
            <title>Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease</title>
            <link>http://www.medworm.com/index.php?rid=4498918&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fwr08369g74761j51%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00401-011-0809-zAuthors
		Hidefumi Ito, Department of Neurology, Kansai Medical University, Osaka, JapanKengo Fujita, Department of Neurology, Kansai Medical University, Osaka, JapanMasataka Nakamura, Department of Neurology, Kansai Medical University, Osaka, JapanReika Wate, Department of Neurology, Kansai Medical University, Osaka, JapanSatoshi Kaneko, Department of Neurology, Kansai Medical University, Osaka, JapanShoichi Sasaki, Department of Neurology, Tokyo Women’s Medical University, Tokyo, JapanKiyomi Yamane, Department of Neurology, Ohta-Atami Hospital, Koriyama, JapanNaoki Suzuki, Department of Neurology, Tohoku University School of Medicine, Sendai, JapanMasashi Aoki, Department of Neurology, Tohoku University School of Medic...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4498918</comments>
            <pubDate>Thu, 17 Feb 2011 08:13:11 +0100</pubDate>
            <guid isPermaLink="false">4498918</guid>        </item>
        <item>
            <title>The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma</title>
            <link>http://www.medworm.com/index.php?rid=4471322&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdv1lnp151u011648%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The neurodegenerative disease glaucoma is characterised by the progressive death of retinal ganglion cells (RGCs) and structural
 damage to the optic nerve (ON). New insights have been gained into the pathogenesis of glaucoma through the use of rodent
 models; however, a coherent picture of the early pathology remains elusive. Here, we use a validated, experimentally induced
 rat glaucoma model to address fundamental issues relating to the spatio-temporal pattern of RGC injury. The earliest indication
 of RGC damage was accumulation of proteins, transported by orthograde fast axonal transport within axons in the optic nerve
 head (ONH), which occurred as soon as 8&amp;nbsp;h after induction of glaucoma and was maximal by 24&amp;nbsp;h. Axonal cytoskeletal abnormalities
 were fi...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4471322</comments>
            <pubDate>Thu, 10 Feb 2011 19:55:56 +0100</pubDate>
            <guid isPermaLink="false">4471322</guid>        </item>
        <item>
            <title>Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI</title>
            <link>http://www.medworm.com/index.php?rid=4471323&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv3621n8832602736%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The close correlation between abnormally low pre-mortem cerebrospinal fluid (CSF) concentrations of amyloid-β1-42 (Aβ1–42) and plaque burden measured by amyloid imaging as well as between pathologically increased levels of CSF tau and the extent
 of neurodegeneration measured by MRI has led to growing interest in using these biomarkers to predict the presence of AD plaque
 and tangle pathology. A challenge for the widespread use of these CSF biomarkers is the high variability in the assays used
 to measure these analytes which has been ascribed to multiple pre-analytical and analytical test performance factors. To address
 this challenge, we conducted a seven-center inter-laboratory standardization study for CSF total tau (t-tau), phospho-tau
 (p-tau181) and Aβ1–...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4471323</comments>
            <pubDate>Thu, 10 Feb 2011 19:55:55 +0100</pubDate>
            <guid isPermaLink="false">4471323</guid>        </item>
        <item>
            <title>New ependymal cells are born postnatally in two discrete regions of the mouse brain and support ventricular enlargement in hydrocephalus</title>
            <link>http://www.medworm.com/index.php?rid=4471324&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc6g21847k336321n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A heterogeneous population of ependymal cells lines the brain ventricles. The evidence about the origin and birth dates of
 these cell populations is scarce. Furthermore, the possibility that mature ependymal cells are born (ependymogenesis) or self-renewed
 (ependymal proliferation) postnatally is controversial. The present study was designed to investigate both phenomena in wild-type
 (wt) and hydrocephalic α-SNAP mutant (hyh) mice at different postnatal stages. In wt mice, proliferating cells in the ventricular
 zone (VZ) were only found in two distinct regions: the dorsal walls of the third ventricle and Sylvian aqueduct (SA). Most
 proliferating cells were monociliated and nestin+, likely corresponding to radial glial cells. Postnatal cumulative BrdU-labeling
 sho...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4471324</comments>
            <pubDate>Thu, 10 Feb 2011 19:55:54 +0100</pubDate>
            <guid isPermaLink="false">4471324</guid>        </item>
        <item>
            <title>Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=4461485&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F71206x20310r1uk7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In the hippocampal formation of Alzheimer’s disease (AD) patients, both focal and diffuse deposits of Aβ peptides appear in
 a subregion- and layer-specific manner. Recently, pyroglutamate (pGlu or pE)-modified Aβ peptides were identified as a highly
 pathogenic and seeding Aβ peptide species. Since the pE modification is catalyzed by glutaminyl cyclase (QC) this enzyme emerged
 as a novel pharmacological target for AD therapy. Here, we reveal the role of QC in the formation of different types of hippocampal
 pE-Aβ aggregates. First, we demonstrate that both, focal and diffuse pE-Aβ deposits are present in defined layers of the AD
 hippocampus. While the focal type of pE-Aβ aggregates was found to be associated with the somata of QC-expressing interneurons,
 the...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4461485</comments>
            <pubDate>Tue, 08 Feb 2011 13:18:18 +0100</pubDate>
            <guid isPermaLink="false">4461485</guid>        </item>
        <item>
            <title>Nerve biopsy: requirements for diagnosis and clinical value</title>
            <link>http://www.medworm.com/index.php?rid=4443109&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3p641t242564327%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In many instances, nerve biopsy is not necessary in the diagnostic work-up of a peripheral neuropathy. However, histological
 examination of a tissue sample is still mandatory to show specific lesions in various conditions involving peripheral nerves.
 As there are fewer laboratories that examine human nerve samples, practitioners including neurologists and general pathologists
 may not be completely aware of the technical issues and data that are provided by nerve biopsy. Nerve biopsy is considered
 an invasive diagnostic method, although, its complications are by far less disabling than most of the disorders that lead
 to its indications. Nevertheless, the decision to perform a nerve biopsy has to be made on a case-by-case basis, and its results
 must be discussed bet...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4443109</comments>
            <pubDate>Fri, 04 Feb 2011 03:33:45 +0100</pubDate>
            <guid isPermaLink="false">4443109</guid>        </item>
        <item>
            <title>Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4443110&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4246803126334n5%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The most common cause of amyotrophic lateral sclerosis (ALS) is mutations in superoxide dismutase-1 (SOD1). Since there is
 evidence for the involvement of non-neuronal cells in ALS, we searched for signs of SOD1 abnormalities focusing on glia. Spinal
 cords from nine ALS patients carrying SOD1 mutations, 51 patients with sporadic or familial ALS who lacked such mutations,
 and 46 controls were examined by immunohistochemistry. A set of anti-peptide antibodies with specificity for misfolded SOD1
 species was used. Misfolded SOD1 in the form of granular aggregates was regularly detected in the nuclei of ventral horn astrocytes,
 microglia, and oligodendrocytes in ALS patients carrying or lacking SOD1 mutations. There was negligible staining in neurodegenerative
 and non-...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4443110</comments>
            <pubDate>Thu, 03 Feb 2011 20:51:18 +0100</pubDate>
            <guid isPermaLink="false">4443110</guid>        </item>
        <item>
            <title>A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts</title>
            <link>http://www.medworm.com/index.php?rid=4443111&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F05784856k3vx55kx%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;O6-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein that removes alkyl DNA adducts such as those induced by
 alkylating agents. Loss of MGMT expression through transcriptional silencing by hypermethylation of its CpG island (CGI) is found in diverse human cancers
 including glioblastomas. Glioblastomas that have MGMT methylation respond to temozolomide, an alkylating agent, resulting in improved survival. Consequently, assessment of MGMT methylation has become a therapy response and prognostic indicator. However, it is not clear whether the region of the MGMT CGI commonly analysed is the critical region involved in transcriptional control. We measured methylation levels at each
 CpG site for the entire MGMT CGI using bisulfite modification and pyrosequ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4443111</comments>
            <pubDate>Thu, 03 Feb 2011 20:51:10 +0100</pubDate>
            <guid isPermaLink="false">4443111</guid>        </item>
        <item>
            <title>Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma</title>
            <link>http://www.medworm.com/index.php?rid=4430226&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjk87212t35835gq7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Missense mutations of the V600E type constitute the vast majority of tumor-associated somatic alterations in the v-RAF murine
 sarcoma viral oncogene homolog B1 (BRAF) gene. Initially described in melanoma, colon and papillary thyroid carcinoma, these alterations have also been observed
 in primary nervous system tumors albeit at a low frequency. We analyzed exon 15 of BRAF spanning the V600 locus by direct sequencing in 1,320 adult and pediatric tumors of the nervous system including various
 types of glial, embryonal, neuronal and glioneuronal, meningeal, adenohypophyseal/sellar, and peripheral nervous system tumors.
 A total of 96 BRAF mutations were detected; 93 of the V600E type and 3 cases with a three base pair insertion between codons 599 and 600. The
 highest f...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4430226</comments>
            <pubDate>Fri, 28 Jan 2011 06:53:11 +0100</pubDate>
            <guid isPermaLink="false">4430226</guid>        </item>
        <item>
            <title>Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups</title>
            <link>http://www.medworm.com/index.php?rid=4412720&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn40r827440106314%2F</link>
            <description>We describe a robust method for detecting
 SHH, WNT, and non-SHH/WNT molecular subgroups in formalin-fixed medulloblastoma samples. In corroborating other studies that
 indicate the value of combining clinical, pathological, and molecular variables in therapeutic stratification schemes for
 medulloblastoma, we also provide the first outcome data based on a clinical trial cohort and novel data on how molecular subgroups
 are distributed across the range of disease.
 
 
	Content Type Journal ArticlePages 1-16DOI 10.1007/s00401-011-0800-8Authors
		David W. Ellison, Department of Pathology MS# 250, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USAJames Dalton, Department of Pathology MS# 250, St. Jude Children’s Research Hospital, 262 Danny Thomas Place,...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4412720</comments>
            <pubDate>Tue, 25 Jan 2011 22:13:11 +0100</pubDate>
            <guid isPermaLink="false">4412720</guid>        </item>
        <item>
            <title>Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy</title>
            <link>http://www.medworm.com/index.php?rid=4401933&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp34765x22qx650p1%2F</link>
            <description>We report that drainage of small molecular weight dextran along cerebrovascular basement membranes is impaired in the
 hippocampal capillaries and arteries of 22-month-old wild-type mice compared to 3- and 7-month-old animals, which was associated
 with age-dependent changes in capillary density. Age-related alterations in the levels of laminin, fibronectin and perlecan
 in vascular basement membranes were also noted in wild-type mice. Furthermore, dextran was observed in the walls of veins
 of Tg2576 mice in the presence of CAA, suggesting that deposition of Aβ in vessel walls disrupts the normal route of elimination
 of solutes from the brain parenchyma. These data support the hypothesis that perivascular solute drainage from the brain is
 altered both in the ageing brain and as a conse...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4401933</comments>
            <pubDate>Sat, 22 Jan 2011 20:12:00 +0100</pubDate>
            <guid isPermaLink="false">4401933</guid>        </item>
        <item>
            <title>Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer’s disease pathology and is independent of tau, Aβ and TDP-43 pathology</title>
            <link>http://www.medworm.com/index.php?rid=4379275&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flpl514741083m401%2F</link>
            <description>This study aims to determine the frequency, severity and distribution
 of PIN1 immunoreactivity and its relationship to NFTs and other neuropathological markers of neurodegeneration such as amyloid-β
 (Aβ) plaques and transcription-responsive DNA-binding protein of M
 r 43&amp;nbsp;kDa (TDP-43). Immunohistochemical analysis of 194 patients (46 with AD, 43 with Parkinson’s disease/dementia with Lewy
 bodies, 12 with progressive supranuclear palsy/corticobasal degeneration, 36 with frontotemporal lobar degeneration, 21 with
 motor neuron disease and 34 non-demented (ND) individuals) revealed an increased frequency and severity of PIN1 immunoreactive
 inclusions in AD as compared to all diagnostic groups (P&amp;nbsp;&amp;lt;&amp;nbsp;0.001). The hippocampal and cortical distribution of PIN1 granules was ...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4379275</comments>
            <pubDate>Mon, 17 Jan 2011 20:24:44 +0100</pubDate>
            <guid isPermaLink="false">4379275</guid>        </item>
        <item>
            <title>Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis</title>
            <link>http://www.medworm.com/index.php?rid=4357308&amp;cid=s_33262_25_f&amp;fid=33262&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb7pn4541q37342k0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cyclic GMP (cGMP)-mediated pathways regulate inflammatory responses in immune and CNS cells. Recently, cGMP phosphodiesterase
 inhibitors such as sildenafil, commonly used to treat sexual dysfunction in humans including multiple sclerosis (MS) patients,
 have been reported to be neuroprotective in animal models of stroke, Alzheimer’s disease, and focal brain lesion. In this
 work, we have examined if sildenafil ameliorates myelin oligodendrocyte glycoprotein peptide (MOG35–55)-induced experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We show for the first time that treatment
 with sildenafil after disease onset markedly reduces the clinical signs of EAE by preventing axonal loss and promoting remyelination.
 Furthermore, sildenafil decreases CD3+...</description>
            <author>Acta Neuropathologica</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4357308</comments>
            <pubDate>Fri, 14 Jan 2011 16:32:57 +0100</pubDate>
            <guid isPermaLink="false">4357308</guid>        </item>
    </channel>
</rss>

